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ABSTRACT
APPLICATION AND DEVELOPMENT OF METHODS FOR ANALYSIS OF 
FUNGAL GLYCOSPHINGOLIPID STRUCTURE AND FUNCTIONAL
INTERACTIONS
by
Emma Adhiambo Arigi 
University of New Hampshire, December, 2007
Fungal lectins from the mushrooms Polyporus squamosus and Coprinus 
cinereus have an affinity for (3-galactosides, with extended binding sites for the 
non-reducing terminal trisaccharide sequence NeuAca2—►6Galp1—>4Glc/GlcNAc, 
and substituted P-galactosides resembling mammalian blood group 
determinants, respectively. In considering the possibility that glycosylinositol 
phosphorylceramides (GIPCs) could be endogenous ligands of such fungal 
lectins, structural characterization of glycosphingolipids (GSLs) from the fruiting 
bodies of these mushrooms was performed. The extraction, isolation and 
purification of the lipids, and their subsequent characterization by nuclear 
magnetic resonance (NMR), mass spectrometry (MS) and gas chromatography- 
mass spectrometry (GC-MS) was performed. One monohexosylceramide (CMH) 
and three major GIPCs were identified from P. squamosus. The GIPCs were 
identified as M anal—>2lns-P-Cer (Ps-1), Gal[31—>6Mana1—^ Ins-P-Cer (Ps-2) 
and Manal ->3Fuca1—>2Gala1-*6Gal(31—»6Mana1—>2lns-P-Cer (Ps-5). Of these 
GSLs, Ps-2 could be a potential ligand for P.squamosus lectin. From C. cinereus,
xv ii
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three components were identified as typical fungal Manal —>2lns-P-Cer 
incorporating unusually short chained ceramides not previously reported in other 
basidiomycetes.
In addition, preliminary studies towards development of high throughput 
methods for glycosphingolipidome analysis were performed. These studies 
explored (i) the use of MS" for disassembly of permethylated glycosylinositols 
(GIs) and (ii) the construction of GSL-based glycan microarrays. MSn analysis of 
GIs efficiently provided useful information on linkage and sequence. An essential 
step in microarray development involved the enzymatic release of the hydroxyl 
fatty acyl of the ceramide moiety of selected fungal GIPCs with sphingolipid N- 
deacylase (SCDase). Derivatives were generated from the reaction of the 
resulting free amino group with A/-reactive F-tag (A/-[4-(1H,1H,2H,2H 
perfluorodecyl)benzyloxycarbonyloxyl]succinimide (Fi7-Cbz-OSu, C2 2 Hi4 F17N0 5), 
and with a linker assembled from succinimidyl-[(A/-maleimidopropionamido)- 
diethyleneglycol] ester (NHS-PEC>2-maleimide) and 2-mercaptoethylamine (2- 
MEA). The derivatives were immobilized via fluorous-flourous affinity, and by 
amide bond formation on W-hydroxysuccinimide-activated micro-glass slides, 
respectively. Preliminary evaluation of their use in assaying protein-carbohydrate 
binding interactions was carried out. The potential utility of this methodology for 
designing microarrays that incorporate both mammalian and fungal GSLs for 
serodiagnosis is discussed.
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Glycosphingolipids (GSLs) are a class of natural products that have been 
identified as important structural and functional elements critical to the life cycle 
of fungi and other eukaryotes. They are present primarily in the plasma 
membranes of eukaryotic cells, localized at the outer leaflet of the membrane, 
with their hydrophilic sugar chains protruding from the surface. GSLs consist of 
one or more monosaccharides linked either directly or indirectly to the primary 
hydroxyl of a lipid moiety called ceramide (in general, any A/-acylsphingoid where 
sphingoid is any member of a family of 1, 3-dihydroxy-2-amino-alkyls and their 
functionalized analogs) (Figure 1.1).
PH  H
OH OH H ' oI I I
H “ c — C —  CH8
NH
c = o
(R = functionalized hydrocarbon)
Figure 1.1 Representative structure of a classical GSL O-D-galactosylceramide).
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Importance of Glycosphingolipids
Although GSLs are essential for the growth of most eukaryotic organisms, 
their precise functional roles are unclear. GSLs are implicated in modulation of 
various cellular events including proliferation, differentiation and apoptosis, cell­
cell interaction and recognition [1]. GSLs mediate host-pathogen interactions in a 
variety of ways. They act as cell surface receptors for viral and bacterial toxins, 
as well as carbohydrate binding proteins (lectins) presented on the surface of 
microbial cells [2, 3]. In addition, sphingolipid metabolites have been implicated 
as key players in cell membrane signal transduction networks and in membrane 
trafficking, both of which serve to regulate infection processes such as pathogen 
invasion and host defense [4]. A modern view of cell membrane structure and 
dynamics holds that surface microdomains called “lipid rafts”, of which GSLs are 
a key component, act as platforms for many functional interactions [5, 6 ], 
including microbial binding, infection signaling, immunoresponse, and entry of 
intracellular parasites [4]. GSLs are also clinically important as ABO and other 
blood group antigens, and as indicators of various pathological conditions. 
Biosynthesis of Glycosphingolipids
The early steps of sphingolipid biosynthesis are conserved in all 
eukaryotes, including mammals and fungi. The structural diversity of 
sphingolipids arises at an early stage from expression of a wide variety of 
ceramide forms, containing sphingoid bases and fatty acids of variable chain 
lengths, degrees of unsaturation, branching and hydroxylation with seemingly
2
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limitless array of polar head group structural variants. Among these, glycans and 
modified glycans provide the major source of GSL structural diversity.
In mammals the principal sphingoid base is D-Eryf/tro-sphingosine while 
D-R/'bo-phytosphingosine is the principal sphingoid base in Saccharomyces 
cerevisiae (Figure 1.2). The corresponding ceramides are referred to as 





Figure 1.2. Structures of sphingoid bases: (A) sphingosine and (B) 
phytosphingosine.
In almost all eukaryotes the enzyme glucosylceramide synthase catalyzes 
the initial step in a major pathway of GSL biosynthesis, the transfer of glucose 
from UDP- glucose to ceramide to form p-glucosylceramide (GlcCer). In 
mammals sphingomyelin synthase catalyzes the transfer of phosphorylcholine 
from phosphatidylcholine to ceramide to form sphingomyelin (SM). Further 
processing of GlcCer by the enzyme (34-galactosyltransferase-T5/T6 to form 
lactosylceramide (LacCer; Gal(31—>4Glc(31Cer) initiates the formation of more 
complex GSLs classified on the basis of their inner core structures as lacto- (Lc), 
neolacto- (nLc), ganglio- (Gg), globo- (Gb), and iso-globo- (iGb) series with the 
sequences Gal(31 —>3GlcNAc|31 —>3Gal(31 -»4Glc(31 Cer,
3
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Galpl -^4GlcNAcpi -^3Gaipi ->4Glcpi Cer,
Galpl ^ 3GalNAcp1 -+4Galp1 -^4Glcp1 Cer,
GalNAcpi —>3Gala1 —>4Gaipi—>4GlcpiCer, and
GalNAcpi—>3Gala1-»3Galp1—>4GlcpiCer [7] and references therein.
On the other hand, the galactosylation of ceramide in a reaction catalyzed 
by galactosylceramide synthase leads to formation of P-galactosylceramide 
(GalCer). GalCer is either sulfated by sulfotransferases to form sulfatides such as 
galactosylceramide-l3-sulfate (GalCer-3-sulfate), neuraminosylated to form the 
ganglioside GM4, or it is further galactosylated to form the gala- and neogala- 
series (poly-[a/p-Gal]6 GaipiCer) of GSLs. Other modifications, such as 
acetylation are also possible. A summary of the biosynthetic pathways leading to 
the formation of major core structures is illustrated in Scheme 1.1. The 
distribution of GSLs varies in different tissues and organs, and at different stages 
of development even within the same organism or species. For example, 
whereas SM and GlcCer are ubiquitiously produced in mammalian tissues, the 
expression of GalCer is limited to certain organs such as brain and nerve tissue, 
and kidney.
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Scheme 1.1. Mammalian GSLs biosynthetic pathway, Glc-T, 
glucosyltransferase; Gal-T, galactosyltransferase; GalNAc-T, N- 
acetylgalactosamine transferase.
Disruption of the GSL biosynthetic pathway interferes with growth and 
development. For example, the complete deletion of the UDP-glucose: ceramide 
glucosyltransferase gene (Ugcg) (also called glucosylceramide synthase (GCS))
5
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in mice caused embryonic lethality; [8 ] cell specific deletion of the same gene in 
the brain resulted in neural defects after birth [9], suggesting the importance of 
GSLs in embryogenesis and neurological development. On the other hand, 
dysfunctional degradation of sphingolipids as a result of a deficiency in one or 
more of the degradative enzymes often causes mental retardation and infant 
lethality, due to abnormal accumulation of toxic metabolites in tissues. The 
inheritable diseases are collectively called sphingolipidoses and include 
Niemann-Pick disease, Gaucher’s disease, Krabbe’s disease, metachromatic 
leukodystrophy, and several forms of gangliosidoses, such as Tay-Sachs 
disease (Figure 1.3).









„  , ,  . , a-galactosidase A-Glc-Gal lactosylceramide -*—2--------------------  -Glc-Gal-Gal
-Glc glucocerebroside 
glucocerebrosidase |  defect = Gaucher’s







A and B  j
-Glc-Gal-Gal-GalNAc
defect = de fe c t- —
Niemann-Pick Krabbe's ' Gai galactocerebroside
Figure 1.3 Summary of pathways for lysosomal degradation of sphingolipids: 
Gangliosides Gmi, Gm2 and GM3 , globosides and gluco- and galactocerebrosides. 
The structures shown are attached to a ceramide core. Gal, galactose; GalNAc, 
/V-acetylgalactosamine; Glc, glucose; NANA, A/-acetylneuraminic acid; Pcholine, 
phosphocholine.
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Fungal Glvcosphinqolipids
Two major GSL biosynthetic pathways exist in fungi. The resulting GSLs 
are distinguished from each other by the relation of their carbohydrate to the 
ceramide moiety. The first group includes “classical” GSLs which have their 
sugar portion directly linked to the ceramide by a glycosidic linkage. With the 
exception of Saccharomyces cerevisiae, most fungi studied so far express 
classical GSLs mainly in the form of monohexosyl ceramides (CMHs) or 
cerebrosides, principally glucosylceramides (Glc(31-Cer) and sometimes 
galactosylceramides (Gal(31-Cer) as terminal products [10-16]. The function of 
Fungal GlcCer synthase gene homologs was first confirmed by Leipelt et al [17]. 
Fungal cerebrosides differ from mammalian ones by the presence of A8 
unsaturation, and methylation on the C-9 of the sphingoid base, with additional 
capability for A3 unsaturation on the fatty acid in some species. The resulting 
ceramide component characteristic to these fungal cerebrosides is a 19 carbon 
(4£,8E)-9-methyl-4,8-sphingadienine (d19:2) in association with a 2-hydroxy-(E)- 
3-alkenoate or 2-hydroxyalkanoate (Fig 1.4) typically 16 or 18 carbons in chain 
length.
7
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Figure 1.4 Structures of fungal cerebrosides: (4E,8E)-N-2’-hydroxyoctadecanoyl- 
1(3-D-galactopyranosyl fatty acid A, Ri=H, R2=OH = GalCer A), (4E,8E)-N-2’- 
hydroxyoctadecanoyl-1(3-D-glucopyranosyl fatty acid A, R^OH, R2=H = GlcCer 
A), 4E,8E)-N-2’-hydroxyoctadecanoyl-ip-D-galactopyranosyl fatty acid A, Ri=H, 
R2=OH e GalCer B), (4E,8E)-N-2’-hydroxyoctadec(E)-3-enoyl-1(3-D- 
glucopyranosyl fatty acid A, R^OH, R2=H = GlcCer B), -9-methyl-4,8- 
sphingadienines, with numbering of sphingosine, hexose and fatty acid moieties.
The disruption of Glc|31-Cer biosynthesis has been found to interfere with 
various aspects of fungal growth and development. Forexample, inhibition of 
UDP-Glc:ceramide glucosyltransferase encoded by GlcCer synthase (GCS) 
genes suppresses spore germination, cell cycle and hyphal development in the 
fungi Aspergillus fumigatus and Aspergillus nidulans [18]. GCS has also been 
identified as a key virulence factor of Crypotococcus neoformans pathogenicity 
by regulating the ability of the fungus to survive in the neutral/alkaline and 
physiological C 0 2 environment upon initial colonization of the extracellular space 
of the alveoli in the lungs [19]. The presence of anti-CMH antibodies in the sera 
of patients with various mycoses suggests that fungal cerebrosides are 
immunogenic [15, 20-22], Various studies have shown that anti-CMHs interfered 
with cell budding and differentiation [20, 21, 23]. Fungal cerebrosides are
8
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therefore not only important for their growth and differentiation but also play an 
important role in infectivity. However, the mechanism by which they perform their 
functions is yet to be established.
The distinguishing feature of the second important class of fungal GSLs is 
the possession of an intervening inositol phosphate between the carbohydrate 
and the ceramide moiety. The GSLs that incorporate this arrangement are known 
as glycosylinositol phosphorylceramides (GIPCs). (Figure 1.5) [24]. The 
ceramide moiety in GIPCs is different from that usually found in cerebrosides, 
and consists of phytosphingosine (1,3,4-trihydroxysphingosine, also called 4- 
hydroxysphinganine) of 18 or 2 0  carbons in length i.e. t18:0 or t2 0 :0 , in 
combination with longer chain saturated 2-hydroxy fatty acids, typically C22, C24 
and C26. This implies that fungi maintain two separate pools of ceramides for 





Figure 1.5 Representative fungal GIPC structure (a-mannosylinositol 
phosphorylceramide).
Biosynthesis of fungal GIPCs begins with the transfer of myo-inositol-1-O-
phosphate (IP) from phosphatidyl inositol to the C-1 hydroxy of phytoceramide to
9
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form inositol-1 -phosphoryl ceramide (IPC), catalyzed by the enzyme inositol 
phosphorylceramide (IPC) synthase (encoded by the AUR1 gene, also called 
IPC1) [1, 15, 17, 26, 27], In S. cerevisiae the mannosylation of IPC to form 
mannosylinositol phosphorylceramide (Mana2IPC, or MIPC) requires the genes 
SUR1 and CSG2. In this yeast the terminal step in sphingolipid biosynthesis is 
the formation of M(IP)2C, (IPMIPC) which requires the IPT1 gene [26], IPC1 has 
been implicated in the modulation of some virulence factors such as melanin 
production of the pathogenic fungus C. neoformans. Research has shown that 
the down regulation of the IPC1 gene not only impaired pathogenicity by lowering 
melanin but also caused a significant decrease in intracellular growth of
C.neoformans [28].
A similar biosynthetic pathway is proposed for other fungi, but with 
diversification leading to other fungal core GIPC structures. The three main core 
structures include Ma2IPC, Ma6 IPC and GlcNa2IPC (where M=Mannose and 
GlcN=Glucosamine) [29-36] (Scheme 1.2). These structures act as scaffolds for 
further glycosylation by a variety of as yet uncharacterized glycosyltransferases 
to yield more complex and structurally diverse GIPCs.
10
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Scheme 1.2. Biosynthesis of fungal GIPCs, starting with transfer of myo-inositol- 
1-O-phosphate (IP) from diacylglycerol (DAG) moiety of phosphatidylinositol 
(IPDAG) to ceramide, catalyzed by AUR1 encoded IPC synthase. The 
observation of three intermediate core structures diverging at the 
monosaccharide level implies the existence of at least three glycosyltransferases 
capable of using IPC as acceptor: (i) Mana2-T (function requires two genes in S. 
cerevisiae, SUR1/CSG1 and CSG2), making Mana2IPC; (ii) Mana6 -T, making 
Mana6 IPC; (iii) GlcNAca2-T, followed by action of de-/V-acetylase, making 
GlcNa2IPC. R-i and R2 may be H or OH; R3 and R4 are (CH2 )nCH3 with variable 
values of n defined by species and other factors.
Further glycosylation of Mana2IPC produces two core structures 
apparently characteristic of basidiomycetes and euascomycetes i.e. Gal(31- 
6Mana2IPC and Maned-3 Mana2IPC, respectively [29, 32, 34, 37-39]. The 
glycosylinositol structural diversity of GIPCs is seen even in closely related 
species such as A  fumigatus and A. nidulans, suggesting possible functional 
roles related to the different glycans expressed [34, 40]. Some GIPCs display 
antigenic properties, e.g., the [3-galactofuranosyl ([3-Galf) containing-GIPCs found 
in Paraccocidioides brasiliensis and A. fumigatus [32, 34]. On the other hand, the 
GIPCs found in A. nidulans appear less strongly recognized by sera from a
11
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patient with aspergillosis [34], These features could be exploited for the 
development of diagnostics based on recognition of GIPCs by serum antibodies 
in patients with mycoses. The structural characterization of fungal GIPCs will aid 
in the development of diagnostics, as well as in functional studies where the role 
of these compounds in life cycle, infectivity and interactions with the host immune 
response may depend on structural features of the glycosylinositol moiety. 
Importance of Fungi
Fungi are major pathogens of agricultural plants and important endemic 
and opportunistic pathogens of humans [41]. The susceptibility to infection by 
opportunistic and other fungal pathogens has risen due to an increase in the 
population of immunocompromised persons, including HIV infected, cancer, 
organ and tissue transplant, and other critically ill patients [42-44]. The common 
opportunistic fungal pathogens include Candida albicans, Aspergillus fumigatus 
and Cryptococcus neoformans [43]. The increased patient population at risk, as 
well as increased resistance to antifungal drugs, has led to a need for 
development of alternative effective chemotherapeutic agents [41, 44].
Differences in the pathways of sphingolipid metabolism in phylogenetically 
different organisms could be exploited for the development of new anti-infectious- 
disease drugs. In fungi, inhibitors of the enzyme IPC synthase have been studied 
as potential targets for development of new antifungals, because this enzyme 
has no mammalian correlate [45-50]. Since ideal antifungal agents would be 
directed at biosynthetic pathways that are uniquely essential to the fungi, these 
efforts can benefit from a better understanding of fungal life cycle and
12
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developmental biology at the molecular level. One of the goals of performing 
structural characterization of GSLs is to aid functional studies. Since the polar 
head groups of the GSLs are structurally diverse even in closely related fungal 
species, the other goal is to exploit this diversity in the development of diagnostic 
or immunodiagnostic agents in the case of antigenic GIPCs.
Structural characterization of GSLs
Structural characterization is an important component of elucidating the 
role of glycoconjugates in development and pathology. Since GSLs have a wide 
variety of structures and physico-chemical properties, traditional methods used 
for their extraction and structural determination are not universal, as they 
generally target a specific subset of GSLs, or GSLs of a particular organism, and 
are not suited for high-throughput (HTP) analysis. In order to improve on the 
current protocols, new methods applicable to a wide range of GSLs, irrespective 
of their structural features and physico-chemical properties, compatible with a 
variety of instrumental analysis, and adaptable for high-throughput applications 
with minimal sample handling, should be developed. The complete structural 
characterization of GSLs requires the analysis of both their ceramide forms and 
their head groups. The main challenge in the structural characterization of 
glycans as opposed to linear biopolymers like proteins and nucleic acids arises 
from different anomeric configurations, multiple hydroxyl linkage sites, 
possibilities for branching, isomerism, and hydroxyl group modifications such as 
sulfation, phosphorylation and acetylation.
13
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Current fungal lipid extraction, fractionation and purification protocols 
require multiple steps (sometimes repeatedly performed), using a variety of 
mixed polarity solvents, in order to obtain lipid fractions that are separated into 
neutral and anionic fractions by anionic exchange chromatography, then further 
purified by preparative high performance liquid chromatography (prep-HPLC), 
column chromatography or preparative high performance thin layer 
chromatography (prep-HPTLC). In order to unambiguously determine glycan 
structure, it is required to determine the identity of all monosaccharide residues; 
their sequence, including branching topology, (if necessary), glycosyl linkage 
sites; anomeric configuration; and the primary structure and linkage of all non­
sugar modifying groups. This process requires the use of a wide array of 
analytical techniques. Complete analysis typically requires nuclear magnetic 
resonance spectroscopy (NMR) and/or mass spectrometry (MS) [40, 51]. In 
addition, other techniques, such as the release of the glycans or glycosylinositols 
(GIs) using enzymes and/or chemical degradation may be used. Finally, 
complete chemical degradation and derivatization may be employed to yield 
suitable derivatives to perform fatty acid, sphingoid, inositol and monosaccharide 
component and linkage analysis by gas chromatography-mass spectrometry 
(GC-MS).
MS is of fundamental relevance to GSL structural determination. Since 
1990, MS instruments of unique analytical capabilities such as matrix-assisted 
laser desorption/ ionization MS (MALDI-MS), electrospray ionization MS (ESI-MS 
and ESI-MSn) and collision induced MS (CID-MS) have typically been used for
14
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analysis of underivatized GSLs in positive or negative ion mode. Cation-adducted 
non-derivatized GSLs and permethylated or otherwise derivatized GSLs have 
been analyzed in positive ion mode either as protonated or cation adducts [52]. 
One dimensional proton or carbon-13 NMR (1-D NMR (1H and 13C) has been 
used to give complementary structural information where sample is limited. In 
situations where sample quantity does not present a limitation, two dimensional 
NMR (2-D NMR) techniques are often used. These techniques all provide useful 
information that is combined to determine structure. Chapter II of this 
dissertation describes the use of conventional protocols for extraction, isolation, 
purification and structural characterization of fungal GSLs.
A frequent problem confounding glycan structural analysis is the 
prevalence of isomeric/isobaric structures sometimes in irresolvable mixtures. 
Recent studies point to a promising future for the use of permethylation, 
traditionally used in protocols for determining glycan sequence and linkage by 
MS and GC-MS, to detect and distinguish various isobars based on the 
abundance of the product ions formed in ion trap multistage MS (MSn) analysis 
[53-55]. In Chapter III of this dissertation I examine the potential use of 
permethylation and MSn for molecular dissection of permethylated 
glycosylinositols (GIs). The MSn analysis of the GIs yields more useful 
information on sequence and linkage in less time than traditional methodologies, 
with a minimal number of derivatization steps.
Attempts to improve methods for GSL characterization have led us to use 
a newly discovered, commercially available enzyme, sphingolipid ceramide-A/-
15
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deacylase (SCDase) from Pseudomonas spp., (Takara Bio, Shiga Japan) [56, 
57], This enzyme provides a means to an alternative derivatization pathway that 
can potentially be utilized for the development of improved methods for GSL 
extraction and analysis. The activity of SCDase on mammalian GSLs has been 
extensively validated and used for removal of the fatty acyl chain of the ceramide 
moiety, while leaving the sphingoid base and glycan intact. One disadvantage of 
the this reaction is that we lose some structural information as a result of the 
removal of the fatty acid; however, this is not an issue when we are dealing with 
GSLs whose ceramide compositions have previously been well established. 
Furthermore, this method can eliminate complexities arising from the distribution 
of the same glycan among ceramide variants differing in chain length and 
functionalization. In Chapter IV I describe the activity of this enzyme toward 
fungal GIPCs, and its use for GIPC derivatization via reaction of the resulting 
lyso-GIPCs with amine reactive reagents. Derivatization of GSLs with 
fluorocarbon affinity tags potentially provides a means of purifying the GSLs by 
fluorous solid phase extraction (F-SPE) or on-line HPLC-based separations.
One of the proposed projects involved constructing GIPC arrays for binding 
studies and HTP analysis of protein-GIPC interactions. Fluorous chemistry 
potentially provides a means to purify and immobilize GSLs using a single tag, 
and should be suitable for developing improved HTP strategies for analysis. 
Chapter IV and V address the development of new strategies utilizing N- 
deacylated GSLs, which are derivatized using fluorocarbon reagents or
16
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bifunctional linkers. Both were studied for potential use in development of GSL- 
based glycan microarrays.
17
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CHAPTER II
CHARACTERIZATION OF GLYCOSPHINGOLIPIDS FROM FUNGI
Characterization of Neutral and Acidic Glvcosphinqolipids from the Lectin- 
Producing Mushroom, Polvoorus sauamosus
Introduction
The polypore mushroom Polyporus squamosus is the source of a lectin 
that exhibits a general affinity for terminal (3-galactosides, but appears to have an 
extended carbohydrate-binding site with high affinity and strict specificity for the 
non-reducing terminal trisaccharide sequence NeuAca2-»6Gal|31—>4Glc/GlcNAc 
[58]. Negligible binding was observed with oligosaccharides bearing the isomeric 
terminal trisaccharides NeuAca2—>3Gal(31—>4Glc/GlcNAc or Galf31—>3 
(NeuAca2—>6 )GlcNAc The specificity of the lectin towards NeuAca2—►6Gal(31—> 
terminated glycans suggests considerable potential for its use in glycobiological 
studies, but its in vivo function is unknown. In considering the possibility that the 
lectins function could involve interaction with an endogenous glycoconjugate, it 
would clearly be helpful to identify candidate ligands among various classes of 
carbohydrate-containing materials expressed by P. squamosus. Since evidence 
has been accumulating that glycosphingolipids (GSLs) may serve as key ligands 
for some endogenous lectins in animal species [59], possible similar roles for 
fungal GSLs could be considered.
18
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Two sub-classes of GSLs appear to be widely expressed in the fungal 
kingdom: (i) monohexosylceramides, such as glucosylceramide (GlcCer) and 
galactosylceramide (GalCer); and (ii) glycosylinositol phosphorylceramides 
(GIPCs), which comprise a structurally diverse class of anionic and zwitterionic 
fungal (and plant) biosynthetic products [13, 29, 30, 32, 36-38, 40, 60-64], 
capable of bearing non-reducing terminal Galp[31—► residues [29, 38]. 
Interestingly, the ceramides found in CMHs of most fungi are structurally distinct 
from those found in GIPCs, suggesting that the corresponding lipid acceptor 
substrates are with few exceptions [15] synthesized in divergent pathways 
adapted for different physiological functional roles [10,11, 14, 18, 65, 6 6 ] 
(compare ceramide structural features in Schemes 2.1 and 2.6). Mushrooms and 
other basidiomycetes that have so far been examined appear to express GlcCer, 
and not GalCer, with typical cerebroside ceramide features widespread in the 
fungal kingdom. In addition, GIPCs of most basidiomycetes have been found to 
possess complex glycans which are highly diversified in structure, but based on a 
characteristic core motif, Gal|31—>6Mana1—>2lns-P-Cer (where Ins = myo-inositol, 
P = phosphodiester, Cer = ceramide; Scheme 2.1, Ba-2). This core has not been 
found in yeasts such as Saccharomyces cerevisiae or Candida albicans, nor in 
filamentous fungi (e.g., euascomycete species); so far the most widely distributed 
GIPC core in euascomycetes has been found to be Mana1^3Mana1—>2lns-P- 
Cer (Scheme 2.1, Eu-2), along with less frequently observed alternate core 
structures based on Maned—>6 lns-P-Cer and GlcNal—>2lns-P-Cer [13, 30, 33,
36, 63]. In this work the extraction and characterization of the major cerebroside
19
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and GIPC components of mature fruiting body of P. squamosus was done using 
one- and two-dimensional nuclear magnetic resonance (NMR) spectroscopy, 
electrospray ionization mass spectrometry (ESI-MS, -MS/CID-MS, and -pseudo- 
[CID-MS]2) in a hybrid quadrupole/time-of-flight (ESI-Qq/oa-TOF-MS) instrument, 
multistep fragmentation in an ion trap-mass spectrometry (ESI-IT-MSn) 







Scheme 2.1. Biosynthesis of fungal GIPCs starting with transfer of myo-inositol-
1-O-phosphate (IP) from diacylglycerol (DAG) moiety of phosphatidylinositol to 
ceramide, catalyzed by AUR1 gene encoded IPC synthase. Common 
intermediate Maned—>2lnsPCer (Ma2IPC) is next synthesized by action of 
Mana2-T (encoded by SUR1/CSG1, CSG2, or both). In S. cerevisae, IPT1- 
encoded protein transfers a second mole of myo-inositol-1 -O-phosphate from 
phosphatidylinositol to Ma2IPC to make PIMa2IPC [24, 67]. In many filamentous 
fungi, an as yet unknown Mana3-T (X) transfers a second a-Man residue to 
Ma2IPC to make a common intermediate Ma3Ma2IPC (right arrow). In most 
basidiomycetes, including mushrooms and Cryptococcus neoformans, an as yet 
unknown Gal|36-T (Y) transfers a |3-Gal residue to Ma2IPC to make a common 
intermediate Gal06Ma2IPC (left arrow).
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Materials and Experimental Methods
Fungal GIPC Fractions
Carpophores of P. squamosus (Huds.) Fr. were collected in late 
summer 1998 from a decaying Ulmus stump in Ann Arbor, Michigan [58]. Freeze- 
dried samples of the fruiting body were used as the source of GSLs for this 
study. The GIPCs were isolated prior to my involvement with the project as 
previously described [40]. Supporting NMR spectroscopy data were acquired by 
Steven B. Levery with experimental details and interpretation of spectra 
described in Arigi et al [6 8 ].
Mass spectrometry
Mass spectrometry of GIPCs was performed in the positive ion mode on a 
Micromass (Manchester, UK) hybrid ESI-Qq/oa-TOF-MS instrument, with GIPC 
sample introduction via direct infusion in 100% MeOH (~100 ng/pL). A nano­
spray capillary tip was employed, from which the flow rate was estimated to be 
~200 nL/min. Mass spectrometry of GlcCer was also performed via positive ion 
mode ESI, but on a linear ion trap (LTQ, ThermoFinnigan San Jose, CA). Lithium 
iodide (10 mM in MeOH) was added to the analyte solution to form predominant 
[M+Li]+ adducts of GlcCer and [M(Li)+Li]+ adducts of GIPC molecular species 
(lithium adduction of GSLs reviewed, [52] the final Lil concentration was ~2-3 mM 
in the former case [13] and ~ 5-6 mM in the latter [35, 40]. Conditions for 
acquisition of GIPC [M(Li)+Li]+ adduct spectra on an ESI-Qq/oa-TOF-MS 
instrument were essentially as described by Bennion et al [40]. Nominal,
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monoisotopic m/z values are used in the labeling and description of +ESI-MS 
results. Interpretation of spectra derived from [M(Li)+Li]+ adducts of GIPC 
molecular species was essentially as described previously [35, 40, 52]. 
Interpretation of ESI-QIT-MS [M+Li]+ profiles and -MSn spectra for GlcCer was 
essentially as described previously for those acquired on triple-quadrupole [13], 
Q-TOF [51], and MALDI-QIT-TOF [7] instruments.
Release and Permethylation of Glycosylinositols
Release of glycosylinositols from GIPCs by ammonolysis was performed 
using 10N NH4OH at 150°C for 24hr as previously described [32].The released 
glycosylinositols were permethylated using the method of Ciucanu and Kerek 
[69] with the modification of Ciucanu and Costello [70]. Briefly NaOH was added 
to the sample dissolved in DMSO and the mixture vortexed to form a white 
suspension, lodomethane was added and the solution further vortexed for 1 hr. 
The reaction was terminated using HPLC grade water and the permethylated 
glycosylinositols were extracted three times using dichloromethane. The extracts 
were combined and dried down under N2.
Glvcosvl Linkage Analysis by GC/MS
The permethylated glycosylinositols (see above) were hydrolyzed and 
derivatized for analysis as partially methylated alditol acetates (PMAAs) using the 
protocols described by Levery and Hakomori [71]. The PMAAs were analyzed on 
an Rtx-5MS bonded phase fused silica capillary column (30 m *0.25 mm; 0.25 
pm phase thickness; Restek Corporation, Bellefonte, PA) in the splitless mode 
using a Trace GC ultra gas chromatograph interfaced to a Polaris Q ion trap
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mass spectrometer, GC/MS (Finnigan MAT, San Jose, CA) operated in El mode.
The GC temperature was programmed essentially as described [32], The
derivatives were identified by retention times and characteristic El mass spectra
compared with those of authentic standards [72, 73].
Monosaccharide. Inositol. Fatty Acid, and Sphingoid Component Analysis bv 
GC/MS
Analysis of the composition of the GIPCs by GC/MS was performed 
following acid catalyzed methanolysis, re-A/-acetylation and preparation of per-O- 
trimethylsilyl (TMS) derivatives. All derivatives were prepared and analyzed 
according to protocols described previously as follows [32, 74-76], Methanolysis 
was carried out with 1N HCI in anhydrous methanol at 80°C, for 16h. At the end 
of this period, the sealed tubes were cooled to room temperature, followed by 
extraction twice with 100pL of n-hexane to extract fatty acid methyl esters 
(FAMEs). The washes were combined in 13x100 teflon-lined-screw-cap vials for 
separate GC-MS analysis. The methanolic HCI was dried under N2 stream at 35- 
40°C. Re-/V-acetylation of the dried residues was then performed to ensure that 
hexosamines, if present, as well as sphingoid bases, would be detected as their 
acetamido derivatives. For this purpose the methanolyzed sample was dissolved 
in 50pL pyridine and 50pL acetic anhydride in 500pL methanol. The sample was 
vortexed and left standing for 2 0  min at room temperature, following which 
evaporation to dryness under N2 at 35-40°C was performed. Per-O- 
trimethylsilylation was done using Tri-sil reagent (Pierce Biotechnology, Inc., 
Rockford, IL). Tri-sil (200pL) was added to the residue, and the test tubes were 
flushed with N2. The sealed test tube was heated for 80°C for 20-30min, after
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which the sample was cooled to room temperature and excess reagent 
evaporated just to dryness under a N2 stream. The white residue was extracted 
twice with n-hexane (100pL) and the washes combined in a small teflon-lined- 
screw-cap vial for GC-MS analysis. Monosaccharides were separated and 
detected as their per-O-trimethylsilyl methyl glycosides. Ceramide-derived 
sphingoid bases and 2 -hydroxyl fatty acids were also separated and detected as 
their A/-acetyl-per-0-trimethylsilyl and 2-O-trimethylsilyl methyl ester derivatives, 
respectively. The derivatives were analyzed by GC-MS according to protocols 
described previously [32]. The identity of the derivatives was based on their 
characteristic retention times and their El mass spectra, compared with data from 
the literature and, where necessary, authentic standards. The instrument used 
was a GCQ (Finnigan MAT, San Jose, CA) operated in electron ionization (El) 
mode. Myo-inositol was detected in the monosaccharide analysis as its per-O- 
trimethylsilyl derivative, although optimal conditions for its release [62] were not 
employed.
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Scheme 2.2. Characteristic fragmentations of glycosylated IPCs, represented by 
MIPC (Ps-1) under conditions of positive ion ESI-Qq/oa-TOF-MS. Panel A, 
nomenclature of Adams and Ann [77] for fragmentation of ceramide moiety, and 
of Costello and Vath [78] and Singh et al. [79] for glycosylinositol phosphoryl 
group; Panel B, sphingoid d3b ion, proposed by Hsu and Turk [80]; Panel C, 
hydrated analog of the d3b ion, poposed in this study as a product of t18:0 or 
t20:0 phytosphingosine-containing ceramides; Panel D, sphingoid Cib ion 
proposed by Hsu and Turk [80]; Panel E, hydrated analog of c1b ion, proposed in 
this study as a product of t18:0 or t2 0 : 0  phytosphingosine-containing ceramides. 
The adduct designation “+Li” and the charge form have been omitted from the 
labels for clarity.
Results
Monosaccharide, inositol, fatty acid, and sphingoid component analysis of P. 
squamosus GIPCs
Following methanolysis of the three putative GIPC fractions of P.
squamosus, i.e., Ps-1, Ps-2 and Ps-5, GC/MS analysis of monosaccharides as
25
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their TMS methyl glycosides showed Ps-1 to consist of mannose as a dominant 
sugar component, consistent with a MIPC. Ps-2 yielded mannose and galactose 
in -2:1 ratio, consistent with a mixture of MIPC and an MIPC derivative with a 
galactose residue added (GalMIPC) in -1:2 ratio. Ps-5 yielded fucose, galactose 
and mannose in -1:2:2 . 6  ratio, suggesting a GIPC with 1 fucose, 2 galactose and
2-3 mannose residues, consistent with the substantially decreased Rf value for 
this fraction. Glucose was detected in all the GIPC fractions; however, based on 
subsequent MS and NMR analysis, its source was considered to be a non-GIPC 
impurity. Myo-inositol was also detected in all the GIPC fractions. The GC/MS 
analysis of the fatty acid methyl esters (FAMEs) and A/-acetyl-sphingoid-0-TMS 
derivatives exhibited abundant peaks for 2 -hydroxy fatty acids and 
phytosphingosines. Ceramides of Ps-1, Ps-2 and Ps-5 were found to be 
composed primarily of (t18:0) 4-hydroxy-sphinganine A/-acylated with h22:0, 
h23:0 and h24:0 in all the fractions (Figures B.1-B.4). The GC retention times 
and El mass spectra corresponding to each of the peaks were identical to those 
of authentic standards. The El spectrum of the A/-acetyl-1,3,4-tri-O-trimethyl- 
(t18:0)-4-hydroxy derivative had peaks corresponding to [M-15]+, [M-15-90]+, 
[M -59-90]+, [M-174]+ and [M -174-90]+ ions observed at m/z 560, 470, 426,
401, and 311 respectively [32, 81]. The long chain monohydroxy fatty acids had 
El spectra with peaks corresponding to [M]+, [M-15]+, and [M-59]+ ions similar to 
previously reported data [76]. Also detected in Ps-1 was a trace of dihydroxy 
fatty acid (dh24:0). The presence of dh24:0 was confirmed using FAME 
derivatives of the threo and erythro forms of 2,3-dihydroxy palmitic acid (dh16:0)
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as standards. Although the precise stereochemistry based on retention times 
was not confirmed, the El spectrum of dh24:0 qualitatively resembled that of 
dh16:0, but with the addition of 112 amu to the major ions observed (Figures 
B.6-B.11). The spectrum was distinctly different from that of the monohydroxy 
fatty acids, with ions corresponding to [M—15]+, [M-59]+, [M -15-90]+, and 
[M-161]+ observed at m/z 543, 499, 453 and 397 respectively (compare results 
of Heise et al [37, 82] and Mayberry [82]).
Glvcosvl Linkage Analysis by GC/MS
The glycosyl linkage structures of Ps-1, Ps-2 and Ps-5 were determined 
by GC/MS of partially methylated alditol acetate derivatives (PMAAs) after 
permethylation of the ammonia released glycosylinositols, followed by 
depolymerization, reduction and peracetylation.
The structure of Ps-1 was confirmed by the detection of a derivative for a 
terminal mannose (t-Manp) residue (1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0- 
methyl-mannitol), consistent with an MIPC (Figure C.1). The linkage analysis of 
Ps-2 yielded derivatives for both terminal galactose and mannose (t-Galp and t- 
Manp) residues (1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-galactitol and 
1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-mannitol, respectively), as well 
as a derivative fora 6 -linked Manp residue (1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tri- 
O-methylmannitol) (Figures C.2-C.3). This is consistent with a mixture of MIPC 
and Gal—>6 MIPC. The linkage analysis of Ps-5 was characterized by the 
detection of a 6 -linked Manp residue, a t-Manp, a 2-linked Galp (1,2,5-tri-O- 
acetyl-1-deuterio-3,4,6-tri-0-methyl-galactitol), and a 6 -linked Galp (1,5,6-tri-O-
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acetyl-1-deuterio-2,3,4,-tri-O-methyl-galactitol) (Figures C.5-C.6). Interestingly, a
3-linked fucose derivative (1,3,5-tri-0-acetyl-1-deuterio-6-deoxy-2,4-di-0-methyl- 
galactitol) was also detected (Figures C.4B). The absence of any branching 
residue derivatives suggested that Ps-5 has an unbranched structure, wherein 
the 6 -linked Manp is assumed to originate from an MIPC core, while the t-Manp 
originates from a mannose residue at the non-reducing terminal. The presence of 
an internal sequence comprised of two galactoses and a fucose residue was also 
indicated, consistent with the monosaccharide analysis.
+ESI-MS and -MS/ClD-MS Analysis of P. squamosus GIPCs 
Ps-1. Major molecular adduct species [M(Li)+Li]+ in the ESI-Q/oa-TOF-MS 
profile of Ps-1 (Figure 2.1) were observed at m/z 1100, 1086, and 1072, 
consistent with monohexosyl-IPCs having ceramides containing t18:0 4- 
hydroxysphinganines with h24:0, h23:0 and h22:0 fatty A/-acylation, respectively. 
The +ESI-MS/CID spectra acquired from the dilithiated molecular adduct at m/z 
1072 and 1100, respectively, were similar to previous +ESI-MS/CID spectra 
obtained from a mushroom MIPC using a triple quadrupole instrument [40], 
exhibiting pairs of non-phosphorylated fragments representing the non-reducing 
end of the glycosylinositol observed at m/z 169 and 187 [Hex+Li]+ ([Bi+Li]+ and 
[Ci+Li]+, respectively), and at m/z 331 and 349 [Hex«lns+Li]+ ([B2 +Li]+ and 
[C2+I_i]+, respectively). A pair of glycosylinositol phosphate fragments 
[Hex«lns«P+Li2]+ were observed at m/z 417 and 435 ([B2 P0 3 (Li)+Li]+ and 
[C2 P 0 3(Li)+Li]+, respectively). Ceramide related product ions from the molecular 
ion m/z 1072 included m/z 644 ([Z0+Li]+), 662 ([Y0+Li]+), 730 ([Z0 PO3(Li)+Li]+),
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and 748 ([y0 PO3(Li)+Li]+), consistent with a t18:0/h22:0 ceramide component. A 
uniform increment of m/z 28 was observed for the ceramide-related products of 
the m/z 1100 molecular ion, i.e. 672 ([Z0+Li]+), 690 ([Y0+Li]+), 758 ([Z0 PO3 
(Li)+Li]+), and 776 ([Y0 PO3(Li)+Li]+) consistent with a t18:0/h24:0 ceramide 
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Figure 2.1. Positive ion ESI-Qq/oa-TOF-MS of Fr 27-30 (Ps-1). A: Molecular ion 
profile as Li adducts.B: MS/CID-MS of [M(Li)+Li]+ at m/z 1072 C: MS/CID-MS of 
[M(Li)+Li]+ at m/z 1100.
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Scheme 2.3. Fragmentation of GIPC Ps-1 in positive ion ESI-Qq/oa-TOF-MS; 
ion designations according to Costello and Vath [78], and Singh et al [79]. The 
adduct designation “+Li” and the charge form have been omitted from the labels 
for clarity.
Ps-2. Two sets of molecular adducts ions were observed in the [M(Li)+Li]+ 
profile of Ps-2 obtained by ESI-Q/oa-TOF-MS. In addition to a group of ions at 
m/z 1100, 1086, and 1072, consistent with the same set of monohexosyl-IPC 
species observed in Ps-1 (data not shown), an abundant second group of 
[M(Li)+Li]+ species could be observed at m/z 1262, 1248, and 1234 (Figure 2.2, 
Panel A). These values correspond to addition of a uniform m/z 162 increment to 
the first group of ions, consistent with addition of a second hexose residue to Ps- 
1. The +ESI-MS/CID spectra from the dilithiated molecular adduct at m/z 1262, 
reproduced in Figure 2.2, Panel B, exhibit an abundant pair of glycosylinositol 
phosphate fragments at m/z 579 and 597, corresponding to [B3 P 0 3(Li)+Li]+ and 
[C3P 0 3(Li)+Li]+ respectively.
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Figure 2.2. Positive ion ESI-Qq/oa-TOF-MS of Fr 31 (Ps-2). A: Molecular ion 
profile as Li adducts.B: MS/CID-MS of [M(Li)+Li]+ at m/z 1262 (low m/z region).
Pairs of ions at m/z 417 and 435, and at m/z 255 and 273, are consistent 
with additional glycosidic cleavages within the glycosylinositolphosphate ion, 
corresponding to [Y2/B3 P0 3 (Li)+Li]+ and [Y2/C3 PO3 (Li)+Li]+, and to 
[Yi/B3P 0 3(Li)+Li]+ and [Yi/C3P0 3 (Li)+Li]+, respectively (see Scheme 2.4). 
Non-phosphorylated glycosylinositol fragments include m/z 493 and 511, 
corresponding to [B3+Li]+ and [C3+Li]+ ions, respectively. Other fragments include 
m/z 331 ([Y2/B2 +Li]+) and 349 ([Y2/C2 +Li]+), and ceramide related ions 672 
([Z0+Li]+), 690 ([Y0+Li]+), 758 ([Z0PO3(Li)+Li]+), and 776 ([Y0 PO3(Li)+Li]+), again 
consistent with a t18:0/h24:0 ceramide component. The data are summarized in 
Tables 1 and 2, Schemes 2.2 and 2.4. Together with the glycosyl composition
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and linkage analysis, these data are consistent with a Gal—>6 MIPC structure for 
Ps-2, with the fraction also containing significant amount of MIPC (Ps-1), and 
with both having similar ceramide component profiles. The complete linkage 
structure and residue configurations in Ps-2 were ultimately confirmed to be 
Gal(31 —>6Mana2IPC by NMR spectroscopy [6 8 ].
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Scheme 2.4. Fragmentation of GIPC Ps-2 in positive ion ESI-Qq/oa-TOF-MS; 
ion designations according to Costello and Vath [78], and Singh et al [79]. The 
adduct designation “+Li” and the charge form have been omitted from the labels 
for clarity.
Ps-5. The major molecular adduct species [M(Li)+Li]+ in the ESI-Q/oa- 
TOF-MS profile of Ps-5 (Figure 2.3, Panel A) are observed at m/z 1732, 1718, 
and 1704, corresponding to the set of Ps-2 molecular adduct ions uniformly 
incremented by two hexose and one deoxyhexose residues ( 2  x m/z 162 + m/z 
146 = m/z 570). Reproduced in Figure 2.3, Panels B and C, are +ESI-MS/CID 
spectra of the dilithiated molecular adduct at m/z 1704, acquired at low collision
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energy and high collision energy, respectively. In these spectra, the fragment at 
m/z 1067 is consistent with an intact glycosylinositol phosphate moiety having 
the expected composition [deoxyHex*Hex4*lns*P+Li2]+ (corresponding to 
[C6P03(Li)+Li]+). Glycosidic cleavages within the glycosylinositol phosphate 
fragment are represented by loss of a hexose residue (m/z 162 decrement), 
yielding an ion m/z 905 ([Y5/C6 P 0 3(Li)+Li]+); loss of a hexose and a deoxyhexose 
residue (m/z 162 + m/z 146 = m/z 308 decrement), yielding a highly abundant ion 
m/z 759 ([Y4/C6 P 0 3(Li)+Li]+); and further sequential losses of residues along the 
chain, yielding ions at m/z 597 ([Y3/C6P 0 3(Li)+Li]+), m/z 435 ([Y2/C 6P 0 3(Li)+Li]+), 
and m/z 273 ([Yi/C6 P 0 3(Li)+Li]+) (see Scheme 2.5). The corresponding 
[B6 P 0 3(Li)+Li]+ fragment m/z 1049 undergoes analogous sequence-specific 
losses of hexose or deoxyhexose residues to yield ions at m/z 741 
([Y4/B6 P0 3(Li)+Li]+), m/z 579 ([Y3/B6 P 0 3(Li)+Li]+), and m/z 255 
[Yi/B6P 0 3(Li)+Li]+). Other significant ions include unphosphorylated fragments 
observed at m/z 1542 ([Y5+Li]+), m/z 1396 ([Y4 +Li]+), m/z 1234 ([Y3+Li]+), m/z 963 
([B6+Li]+) and m/z 981 ([C6+Li]+). Summarized in Tables 1 and 2, and Schemes 
2.2 and 2.5, these data are consistent with a pentaglycosyl-IPC structure for PS- 
5, which must have the linear sequence Hex-deoxyHex-O-Hex-O-Hex-O-Hex-O- 
InsPCer to be consistent with the results of the glycosyl linkage analysis.
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Figure 2.3. Positive ion ESI-Qq/oa-TOF-MS of Fr 33-34 (Ps-5). A: Molecular ion 
profile as Li adducts. B: MS/CID-MS of [M(Li)+Li]+ at m/z 1704, low collision 
energy (57 eV) and C: MS/CID-MS of [M(Li)+Li]+ at m/z 1704, high collision 
energy (78 eV).
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Scheme 2.5. Fragmentation of GIPC Ps-5 in positive ion ESI-Qq/oa-TOF-MS; 
ion designationsaccording to Costello and Vath [78], and Singh et al [79], The 
adduct designation “+Li” and the charge form have been omitted from the labels 
for clarity.
The terminal hexose must be a mannose residue (T-Man) based on 
linkage analysis. The abundant fragments at m/z 1396, 759, and 741, 
corresponding to combined losses of a hexose and a deoxyhexose residue (m/z 
308 decrements from the molecular adduct ion and the two glycosylinositol 
phosphate ions) imply that the —>3Fuc residue identified in the linkage analysis 
represents the penultimate residue to which the terminal Man is attached. Given 
the likely assumption that the other Man residue identified in the linkage analysis 
(—>6 Man) is directly linked to IPC to form a ManlPC core, the next two internal 
hexoses in the sequence must be the —>2Gal and —>6 Gal residues observed in 
the linkage analysis, one of which must be linked 1— > 6  to the ManlPC core. The 
order of the -^2Gal and —>6 Gal residues is not further specified by any of the 
data so far. Overall, the data are consistent with the partial sequence
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Man—>3Fuc—>2/6Gal—>6/2Gal—>6ManlPC. The complete linkage sequence and 
residue anomeric configurations in Ps-5 were ultimately determined by ESI-IT- 
MSnof the permethylated glycosylinositol and 1- and 2-D NMR methods to be 
Maned—►SFuccrt—>2Gala1—>6Gal(31—>6ManalPC [68].
TABLES DESCRIBING FRAGMENTATION
Table 2.1. Molecular adduct ions [M(Li)+Li] observed in ESI-Q/-TOF-MS profile (A), and significant 
ceramide-containing product ions (m/z) formed in low energy Q-TOF ESI-MS/CID-TOF-MS spectra of 
mono-, di-, and pentaglycosylinositol phosphorylceramides from fruiting body of P. squamosus (Ps). 
Fragment designations as in Costello and Vath[78], as expanded for GIPCs in Singh et al [79], with 
modifications of Adams and Ann [77] for ceramide-derived ions; illustrated in Schemes 2.3-2.5.
Fraction: Ps-la Ps-lb Ps-2 Ps-5
Fatty acid h22:0 h24:0 h24:0 h22:0
Sphingoid: tl 8:0 tl8:0 tl 8:0 tl8:0
[M (L i)+L i]+: 1072 1100 1262 1704
[M(Li) -  Hex+Li]+ 910 938 1100 1542
[M(Li) -  Hex -  dHex + L if — . . . . 1396
[M(Li) -  2Hex -  dHex + Li]+ 1234
[M(Li) -  3Hex -  dHex + Li]+ — 1072L
[Y0PO3(Li)+Li]+ 748 776 776 748
[Z0PO3(Li)+Li]+ 730 758 758 730
[Z0PO3(Li)+Li-H2O]+ 712L 712L 740La -
[Y0+Li]+ 662 690 690 662
[Z0+Li]+ 644Va 672 672La -
[O/Z0PO3(Li)+Li]+ 392 392 392L —
aL = low-abundance ion
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Table 2.2. Glycosylinositol- and phosphorylglycosylinositol-related product ions formed in low energy 
ESI-MS/CID-TOF-MS spectra of mono-, di-, and pentaglycosylinositol phosphorylceramides from fruiting 
body of P. squamosus (Ps). Base peak distinguished by bold font. Fragment designations as in Costello 
and Vath [78], as expanded for GIPCs in Singh et al [79], illustrated in Schemes 3-5.











819 [Y5/C6+Li]+ or [C5+Lif
801 [Y5/B6+Li]+ or [B5+Li]+
11T [Y4/C6P03 + H20  (Li)+Li]+





579 [B3P 0 3(Li)+Li]+ [Y 3/B6P03(Li)+Li]+
511 [C3+Li]+ [Y3/C6+Li]+
493 [B3+Li]+ [Y3/B6+Li]+ or [Z3/C6+Li]+
453a [C2P03+H 20(Li)+Li]+ [Y2/C2P 03 + H20  (Li)+Li]+
435a [C2P 0 3(Li)+Li]+ [Y2/C3P03(Li)+Li]+ [Y2/C6P 03(Li)+Li]+
417 [B2P03(Li)+Li]+ [Y2/B3P 03(Li)+Li]+ [ Y 2/B6P03(Li)+Li]+
349 [C2+Li]+ [Y2/C3+Li]+ or [C2+Li]+ [Y2/C6+Li]+
331 [B2+Li]+ [Y2/B3+Li]+ or [B2+Li]+ [Y2/B6+Li]+
29 la [Y1/C2P03 + H20  (Li)+Li]+ [Y ]/C3P03 + H20  (Li)+Li]+
273 [Y!/C2P03(Li)+Li] [Y,/C3P 03(Li)+Li]+ [Y,/C6P 03(Li)+Li]+
255 [Y,/B2P 03(Li)+Li] [Y ,/B3P 03(Li)+Li]+ [Y1/B6P 03(Li)+Li]+
237 [Z1/B2P 03(Li)+Li]+ [Z1/B3P 03(Li)+Li]+ [Z,/B6P 03(Li)+Li]+
187 [C,+Li]+ [Yj/C3+Li]+ or [Ci+Li]+ [Ci+Li]+
169 [B|+Li]' [Y!/B3+Li]+ or [Bi+Li]+ [B,+Li]+
111 [LiH2P04+Li]+ [LiH2P04+Li]+ [LiH2P 04+Li]+
aApparent H20  adducts do not appear consistently, and are considered to be artifacts.
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+ESI-MSn Analysis of P. squamosus Monohexosvl Ceramide
The major molecular ion species [M+Li]+ in the ESI-MS1 profile of the CMH 
fraction (Figure 6, panel A, Inset) observed at m/z 734 is consistent with a 
lipoform having a h16:0/d19:2 fatty acyl/sphingoid combination. The MS2 spectra 
acquired from this adduct reproduced in Figure 2.4, Panel A, is analogous to 
previously reported findings using low energy tandem [13, 51] and ion trap [7] 
instruments, with characteristic ions at m/z 572 and 480 representing the loss of 
a hexose residue (Yo fragment) and the h16:0 fatty acid residue (O fragment) 
respectively (see Scheme 2.6). The h16:0 fatty-N-acyl group is included in the 
characteristic ion at m/z 304 (T = Z0/G fragment), although this fragment appears 
at much greater abundance in low energy tandem MS/CID-MS spectra [13, 51] 
than in ion trap MSn spectra [7]. Further dissection of these primary precursors 
via MS3 confirmed their presumptive origins and structural significance. Key MS3 
products of m/z 572 (Figure 2.4, Panel B) included the characteristic d19:2 
sphingoid (N = Yo/G) ion m/z 318, and the h16:0 fatty-N-acyl W ion m/z 233. Key 
MS3 products of m/z 480 (Figure 2.4, Panel C) also included the characteristic 
d19:2 sphingoid N ion m/z 318, as well as hexose ions m/z 169 (B-i) and 187 
(Ci), and a pair of fragments from losses of NH3 (m/z 463) and H20  {m/z 462) 
(the O fragment and the latter two products correspond to ions designated g-i, g2, 
and g3, respectively, by Hsu and Turk [80],
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Figure 2.4. Positive ion ESI-MSn analysis of purified GlcCerfrom P. squamosus. 
A: MS1 lithium adduct ion profile showing predominant adduct at m/z 734 (inset) 
and MS2 product ion spectrum of selected precursor at m/z 734. B: MS3 product 
ion spectrum of selected Y0 fragment precursor at m/z 572 (m/z 734—>572—►). C: 
MS3 product ion spectrum of selected O fragment precursor at m/z 480 (m/z 
734—>480—»).
39







Scheme 2.6. Structure of prototypical fungal glucosylceramide, (4E,8E)-A/-2”- 
hydroxyhexadecanoyl-1-(3-D-glucopyranosyl-9-methyl-4,8-sphingadienine, along 
with fragmentation nomenclature of Costello and Vath [78] as modified by Adams 
and Ann [77].
Discussion
In this work, both types of fungal GSLs, monohexosylceramide and 
GIPCs, were extracted from the fruiting body of P. squamosus and characterized. 
The P. squamosus monohexosylceramide was found to be GlcCer exclusively, 
as previously observed for basidiomycete species, with a typical basidiomycete 
structure characterized by the absence of fatty-A/-acyl A3-unsaturation, the 
predominant ceramide having an h16:0/d19:2 fatty-/V-acyl/sphingoid composition 
(for extended reviews of fungal GlcCer structure, biosynthesis, and function, see 
[15, 66]. The structures of three major GIPCs, Ps-1, Ps-2, and Ps-5, were 
elucidated, with the latter found to have a previously unreported 
pentaglycosylinositol headgroup structure. The ceramide moieties of the GIPCs 
had typical phytoceramide structures found in other fungi. [15, 66]. The
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
predominant GIPC sphingoid was found to be t18:0 4-hydroxysphinganine 
(phytosphingosine), in combination with h22:0 and h24:0 as the predominant 
long-chain fatty-/V-acyl moieties. In Ps-1, dihydroxy fatty-/V-acylation (dh24:0) 
was also detected as a minor component. Ps-1 represents a common Mana2IPC 
core structure found in many fungi [13, 29, 32, 37, 40, 83]; Ps-2 represents 
modification of Mana2IPC by addition of a Gal(36 residue to form 
Gaip6Mana2IPC (Ba-2; see Scheme 2.1), a core structure typical of almost all 
basidiomycete species so far characterized [37, 39, 83], while not being 
observed in other types of fungi, such as saccharomycetales (e.g., 
Saccharomyces and Candida spp.) or euascomycetes (filamentous or thermally 
dimorphic species, e.g., Aspergillus spp., Histoplasma capsulatum, 
Paracoccidioides brasiliensis, Sporothrix schenckii). Ps-5 was found to have the 
structure Mana3Fuca2Gala6Gal(36Mana2IPC, consistent with sequential 
elongation of Ps-2/Ba-2 with three additional monosaccharide residues. All three 
of these residues, Gala6, Fuca2, and Mana3, have been observed previously in 
mushroom GIPCs, but so far not in a strictly linear sequence as found for Ps-5.
Understanding fungal GSL functions, particularly in terms of their 
interactions with endogenous carbohydrate- or lipid-binding proteins at the 
molecular level, is at a very early stage. The lectin from P. squamosus strongly 
recognizes NeuAca2-^6Gaipi-^ terminated glycans; the lectin also recognizes, 
albeit more weakly, non-sialylated terminal Gal residues [58, 84], Ps-2/Ba-2, 
which makes up a significant fraction of P. squamosus GIPCs, does possess a 
terminal 3-Gal residue, suggesting it could potentially interact with P.squamosus
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or other fungal lectins. Future work could involve the study of possible 
interactions of fungal GIPCs with lectins from P. squamosus and other 
mushrooms. Such further investigations could provide insights on the role of 
GIPCs in the fungal life cycle and developmental biology.
Characterization of Glycosphingolipids from the Mushroom 
Coprinus cinereus
Introduction
Lectins are proteins (sometimes, glycoproteins) that bind specifically and 
reversibly to carbohydrates. They are found in a variety of organisms including 
plants, animals and fungi. The mushroom Coprinopsis cinerea (alternatively 
Coprinus cinereus) also produces lectins (galectins), which bind galactose- 
containing glyconjugates. Galectins are a ubiquitously distributed family of 
carbohydrate-binding proteins that were initially defined, on the basis of structural 
analysis and binding-specificity studies, to have a binding affinity for (3 - 
galactosides, and in addition display conserved sequence elements in the 
carbohydrate-binding site [85]. The galectin CGL2 isolated from the C.cinereus 
fruiting body has an affinity for (3-galactosides with and extended binding affinity 
for substituted (3-galactosides resembling mammalian blood group A 
tetrasachharide GalNAca1-3[Fuca1-2]Gal(31-4Glc and B type determinants in the 
extended binding site [86]. The differential expression and high regulation of 
Coprinus galectins during different stages of fruiting body development suggests 
that they play important functional roles during development [87]. Since recent 
work has suggested that one or more GIPCs of C. cinereus may be potential
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ligands for these lectins during early development [86], this study was aimed at 
identifying likely endogenous ligands for C. cinereus lectins. In this work the 
structural characterization of GIPCs from the fruiting body and mycelia of C. 
cinereus was performed using 1-D 1H-NMR and ESI-MS.
Experimental Materials and Methods
Fungal Isolate
Freeze dried samples of the fruiting body and mycelia of the mushroom C. 
cinereus obtained from Markus Kunzler (Swiss Federal Institute of Technology 
Zurich, Switzerland) were used as the source of GSLs for this study. They were 
grown and harvested as described [87].
High Performance Thin Laver Chromatography
Analytical HPTLC was performed on silica gel 60 plates (E. Merck, 
Darmstadt, Germany) using chloroform/methanol/water (50:47:14 v/v/v, 
containing 0.038% w/v CaCI2; solvent C) as mobile phase for acidic lipids, and 
chloroform/methanol/water (60:40:9 v/v/v, containing 0.025% w/v CaCI2; solvent 
D) for neutral lipids. Acidic lipid samples were solubilized in 
isopropanol/hexane/water; solvent A (55:25:20, v/v/v, upper phase discarded) 
and applied by streaking from 5 pL Micro-caps (Drummond, Broomall, PA). 
Neutral lipid samples were solubilized in chloroform/methanol; solvent B (1:1, v/v) 
and applied similarly. Detection was made by Bial’s orcinol reagent (orcinol 
0.55% [w/v] and H2SC>4 5.5% [v/v] in ethanol/water 9:1 [v/v]; the plate is sprayed 
and heated briefly to ~200-250°C).
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Extraction and Purification of Glycosphinqolipids 
Extraction, fractionation into neutral and acidic lipids on DEAE-Sephadex 
ion exchange chromatography, and purification of acidic GIPCs from the DEAE- 
Sephadex-retained fraction by preparative-scale HPLC, were carried out as 
described previously [40]. The identity and purity of each acidic fraction from 
HPLC was assessed by analytical HPTLC using solvent C as above, and those 
containing putative GIPCs were further assessed by 1-D 1H-NMR spectroscopy 
and MS techniques described below. (A summary of the extraction, fractionation 
and purification steps is shown in Scheme 2.7 below).
Total lipid extraction using 




Fractionation DEAE-sephadex anion 







Base treatment with 25% 
methylamine in
methanol/water/n-butanol 4:3:1 












Preparative-scale HPLC and or 
prep-TLC
Scheme 2.7. Fungal lipid extraction, fractionation and purification.
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1-D 1H Nuclear Magnetic Resonance Spectroscopy
Samples of underivatized GIPC (~ 0.5-1.0 mg) were deuterium 
exchanged by repeated lyophilization in D20 . The samples were dissolved in 0.6 
ml_ DMSO-d6/2% D20  [88] for NMR analysis as described [30, 32, 40, 64]. 1-D 
1H-NMR experiments were performed at 35°C on Varian Unity Inova 500 MHz 
(Department of Chemistry, University of New Hampshire), spectrometer, using 
standard acquisition software available in the Varian VNMR software package. 
Electrosprav-lonization-MS Analysis
ESI-MS was performed on a Thermo-Finnigan (San Jose, CA) LCQ. 
Samples were dissolved in methanol, and introduced by direct infusion at a flow 
rate of 1 .OpL/min (spray voltage = 2.0 kV, capillary temperature = 200°C, 
capillary voltage = 46.00 V, tube lens offset = 50.00 V).
Results and Discussion
HPTLC analysis of the neutral fractions showed each contained one 
component with an Rf that corresponds to glucosylceramide (Figure 2.5). Since 
this was not of particular interest for this study, no further analysis of this 
component was undertaken. In the crude acidic GSL fractions from the fruiting 
body, one major component was observed with Rf value identical to that of the 
MIPC obtained from P. squamosus (Ps-1) (Figure 2.6). On subjection to HPLC 
purification three bands of slightly different Rf, designated fractions 29, 30 and 
31, were obtained (see Figure D.1).
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Figure 2.5. HPTLC (orcinol stain) of neutral lipids from C.cinereus. Mobile phase 
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Figure 2.6. HPTLC (orcinol stain) of GIPCs from C.cinereus. Mobile phase 
chloroform-methanol-water (50:47:14 v/v/v) containing 0.038% w/v CaCk. Lane 
S, GIPC standard containing Mana2IPC (MIPC), Gal|36Mana2IPC (GMIPC), and 
Mana3Fuca2Gala6Gal(36Mana2IPC (Pentaglycosyl complex); Lane 1-3 crude 
acidic fractions from C.cinereus fruiting body.
1H-NMR spectroscopy
Downfield expansions of the 1-D 1H-NMR spectra of acidic fractions 29, 30
and 31 (Figure D.2) exhibited a lone H-1 resonance at 5.045 ppm, typical for a-
Man of a fungal MIPC, as previously observed [30, 38, 89].
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ESI-MS analysis
The positive ion mode MS spectra of the purified GIPC fractions from the 
fruiting body of C.cinereus are displayed in the figures below. The molecular ion 
profiles as lithium adducts exhibited major species differing by 14 or 28 amu 
consistent with lipoforms (ceramide variants) differing by one or two CH2 units in 
the sphingoid or fatty acid, or both. Other ions that are incremented by 134 or 
268 amu from the major molecular ions represent lithium iodide (Lil) or (Lil2) 
adducts, respectively [7]. Molecular ions were selected and subjected to MS2 
analysis as follows: Fraction 29 ions at m/z 1100 and 1128 (Figure 2.7 A), 
fraction 30 ions at m/z 1072 and 1086 (Figure 2.8 A) and fraction 31 ions at m/z 
988 and 1016 (Figure 2.9 A). It is evident from the different MS2 results that the 
differences in m/z correspond to lipoforms of MIPC. Upon subjection of the 
ceramide-related [Y0+Li]+ ions at m/z 662 and 676 from fraction 30 (Figure 2.7 B 
and C) to MS3 analysis (Figure D.2) both yielded identical sphingoid-related 
ions at m/z 291 and 324, suggesting that fatty acids of various chain lengths and 
not the sphingoid base give rise to the ceramide variants evident from the MS2 
results in this fraction. This analysis has not yet been performed on fractions 29 
and 31. A summary of the MS results can be found in Table 2.3 and 2.4. In my 
structural characterization of GSLs from C. cinereus the main GIPC component 
identified was a M anal—>2lns1-P-1Cer. I was unable to find any GIPC with an 
additional (3—Gal or other residue. TLC results and corresponding 1H-NMR data 
are presented in Figure D.2. Similar results were obtained for fractions isolated 
from C. cinereus mycelia (data not shown).
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Figure 2.7. A: Molecular ion profile of Fr 29 as Li adducts. B: MS2 of m/z 1100 
and C: MS2 of m/z 1128.


























Figure 2.8. A: Molecular ion profile of Fr 30 as Li adducts. B: MS2 of m/z 1072 
and C: MS2 of m/z 1086.
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Figure 2.9. A: Molecular ion profile of Fr 31 as Li adducts. B: MS2 of m/z 988 and 
C: MS2 of m/z 1016.
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TABLES DESCRIBING FRAGMENTATION
Table 2.3: Molecular adduct ions [M(Li)+Li]+ observed in ESI-MS profile (A) and 
their product ions (B) obtained from ESI-MS2 of glycosylinositol 
phosphorylceramides from fruiting body of C. cinereus.
Fraction: 29 29 30 30 31 31
A. [M(Li)+Li]+: 988 1016 1072 1086 1 1 0 0 1128
B.Products of [M(Li)+Li]+:
[M(Li)-Hex+Li]+ 826 854 910 924 938 966
[Y0PO3 (Li)+Li]+ 664 692 748 762 776 804
[Z0PO3 (Li)+Li] + 646 674 730 744 758 786
[Y0+Li] + 578 606 662 676 690 718
[Z0+Li]+ 560 588 644 658 672 700
Table 2.4: Glycosylinositol ions from ESI-MS spectra of monoglycosylinositol 
phosphoryceramides from fruiting body of C. cinereus.
Fragmentation designations m/z
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CHAPTER III
MSn ANALYSIS OF PERMETHYLATED GLYCOSYLINOSITOLS
Introduction
In order to unambiguously determine a complete glycan structure it is 
generally necessary to employ a variety of analytical techniques. Several of 
these techniques require the generation and utilization of permethylated 
derivatives for mass spectrometry. Permethylation confers various advantages 
that are particularly useful for mass spectral characterization, the most important 
of which is elimination of ambiguities with respect to linkage and branching 
topology that can compromise mass spectral analysis of native samples [54]. In 
addition, the hydrophobic nature of the permethylated samples makes them 
amenable to organic solvent extraction procedures and often enhances signal 
intensity in positive ion modes. Combining permethylation with the MSn 
capabilities of ion trap MS (IT-MS) allows maximization of useful structural 
information related to linkage, sequence, and in some cases monomer 
stereochemistry resulting from the ions generated via glycosidic bond cleavages 
and sugar ring (cross-ring) cleavages [53-55, 90-92] (Scheme 3.1).
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Scheme 3.1. Nomenclature of major fragment sugar ions are numbered from: 
The reducing end for X, Y and Z and from the non-reducing end for A, B and C 
ions.
I am interested in the potential of MSn for molecular dissection of 
permethylated glycosylinositols (GIs) of fungal GIPCs. Application of 
permethylation on intact GIPCs is limited by the base lability of the phosphate 
bond, which undergoes various degrees of degradation to form by products as a 
consequence of the loss of the ceramide or ceramide phosphate. To assure 
complete derivatization of a single entity, the release of GIs prior to 
permethylation was performed.
In Chapter II a second technique requiring permethylation, the glycosyl 
linkage analysis, where methylated glycoconjugates or oligosaccharides are 
hydrolysed, reduced and acetylated to generate partially methylated alditol 
acetates (PMAAs), which are then analyzed by GC/MS against authentic 
standards was utilized. This is the most unambiguous method for determining 
linkage sites in a glycan, but generally reveals little about the actual sequence of 
residues. The generation of PMAAs is also very technique and labor intensive. In 
this chapter the potential use of MSn for structural characterization of
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permethylated intact glycosylinositols, where information about both sequence 
and linkage topology can be obtained with considerably less sample 
manipulation is shown.
Experimental Methods
Extraction and purification of GIPCs
Fungal GIPCs from various sources were extracted and purified using the 
protocols described in Chapter II. The purified GIPC fractions were analyzed by 
NMR and MS and structures verified using already published data [37, 40, 83]. 
Mass spectrometry analysis
Following the base release of GIs under high temperature and subsequent 
permethylation as described previously (Chapter II) the derivatives were 
subjected to positive ion mode ESI-MSn analysis. MS analysis was performed on 
a quadrupole ion trap instrument (LCQ, Finnigan MAT, San Jose, CA) samples 
dissolved in methanol, loaded into a 100 pL syringe attached to the electrospray 
source (spray voltage = 2.0 kV, capillary temperature = 200°C, capillary voltage = 
46.00 and introduced by direct infusion at a flow rate of 1.0 pL/min) or on a linear 
ion trap mass spectrometer (LTQ, ThermoFinnigan, San Jose, CA), parameters 
described in Ashline et al. [54].
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Results and Discussion
Positive ion mode ESI-IT-MSn of permethylated glvcosvlinositols
The behavior of permethylated GIs under the conditions of positive ion 
mode MSn analysis is illustrated in the subsequent figures. As shown in Figure 
3.1, the isobaric molecular ion adducts at m/z 695 are produced by isomeric 
intact permethylated diglycosylinositols. Primary product ions resulting from inter- 
glycosidic bond cleavages are pyranosyl-1-ene and complementary open 
hydroxyl B- and Y-type ions at m/z 241, 273, 445, 477; open hydroxyl C- type 
ions are observed at m/z 259 and 463 (nomenclature suggested by Domon and 
Costello) [54, 93] (Schemes 3.2 and 3.3). Complementary Z-type ions are not 
abundantly observed in these spectra. The loss of a permethylated inositol 
residue (250 amu) from the reducing end produces isobaric terminal 
disaccharide-1-ene fragments at m/z 445. This loss is characteristic of GIs and 
labels the non-reducing end glycan fragments unambiguously, unlike the case 
with permethylated polyhexose oligosaccharides, from which monosaccharide 
units lost form either end can produce isobaric primary fragments. The MS3 
analysis of the precursor disaccharide-1-ene fragments is most important 
because it gives rise to unique product ion sets for the two GIs as a consequence 
of available cross-ring cleavage pathways. In Figure 3.2 B the ion at m/z 329, 
and absence of m/z 315 and 371, are characteristic of a 1 —* 6 linkage (Scheme 
3.2) while in Figure 3.3 B, ions at m/z 315, 343, 371 and absence of m/z 329 
(Scheme 3.3), are characteristic for a 1 —> 3 linked hexose residue [54]. The
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Figure 3.1. Positive ion mode MS1 profile of permethylated diglycosylinositol 
from A: A.fumigatus GIPC M anal—>3Mana2IPC and B: P.squamosus GIPC 
Gaipi —>6Mana2IPC.
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Figure 3.2. Positive ion mode ESI-MSn of permethylated diglycosylinosito! from 
P.squamosus GIPC Gal|31-»6Mana2IPC. A: MS2 product ion spectrum m/z 695 
—> and B: MS3 product ion spectrum m/z 695 —► m/z 445 —
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477
FNa - MeOH = m/z 663 463
FNa - MeOH - CH20  = m/z 633
FNa+ = m/z 445
FNa+ - MeOH = m/z 413
FNa+ - MeOH - CH20  = m/z 383
Scheme 3.2. Fragmentation of m/z 695 ion produced by positive ion mode MS2 
and of m/z 445 ion produced by positive ion mode MS3 of permethylated 
diglycosylinositol Gal(36Mana2lns.
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Figure 3.3. Positive ion mode ESI-MSn of permethylated diglycosylinositol from 
A.fumigatus GIPC M anal—>3Mana2IPC. A: MS2 product ion spectrum m/z 695 
—► and B: MS3 product ion spectrum m/z 695 —► m/z 445 —
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FNa+ = m/z 695
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h3co  o c h3
FNa+ = m/z 445 
FNa+-MeOH = m/z 413 
FNa+ - MeOH - CH20  = m/z 383
Scheme 3.3. Fragmentation of m/z 695 ion produced by positive ion mode MS2 
and of m/z 445 ion produced by positive ion mode MS3 of permethylated 
diglycosylinositol Mana3Mana2lns.
As shown in Figure 3.4 the isobaric molecular ion adducts at m/z 
899 are produced by isomeric intact permethylated triglycosylinositols one linear, 
the other branched. The MS2 analysis of these precursor ions results in 
glycosidic cleavages to produce distinct spectra Figures 3.5 A, 3.6 A; Schemes
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3.4, 3.5) Both have prominent fragments at m/z 681 (produced by loss of one 
non-reducing hexose residue) and significant Y fragments at m/z 649 (loss of 
inositol), but lower m/z ions reflect the different linkage topologies in the two GIs. 
For example the abundant Y fragment m/z 477 and B fragment m/z 445 can only 
be produced by the linear Gl (Figure 3.5 A, Scheme 3.4) The MS3 analysis of 
the isobaric precursor trisaccharide-1-ene ion at m/z 649 produces a dominant 
disaccharide-1-ene fragment at m/z 445 (Figure 3.5 B). A cross-ring cleavage 
ion at m/z 575 consistent with a 3-linked diglycosyl fragment is also formed. As 
shown in Figure 3.6 B, Scheme 3.5, the MS3 analysis of m/z 649 from the 
branched trisaccharide-1-ene produces ions at m/z 413 and 431 from glycosidic 
cleavages, and a cross-ring cleavage ion at m/z 371 characteristic of the loss of 
the branching 1-6 linked hexose residue.
On subjection to MS4 analysis, the disaccharide-1-ene fragment at 
m/z 445 undergoes cross-ring cleavages to give characteristic ions at m/z 343 
and 371 (Figure 3.5C). The absence of an ion at m/z 315 eliminates the 
possibility of having a 3-, 4- or 6-linked residue and suggests the presence of a 
1-2 linked residue. Overall, the fragmentation pattern does not resemble those 
for 3-, 4- or 6-linked disaccharide-1-enes (Ashline, Singh et al. 2005, [54] and 
compare Figures 3.2, 3.3).
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Figure 3.4. Positive ion mode MS1 profile of permethylated triglycosylinositol 
from A: A.nidulans GIPC Mana3(Mana6)Mana2IPC and B: A.fumigatus GIPC 
M anal—>2l\/lana1—>3Mana2IPC.
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Figure 3.5. Positive ion mode ESI-MSn of permethylated triglycosylinositol from 
A.fumigatus GIPC Mana1->2Mana1—>3Mana2IPC. A: MS2 product ion spectrum 
m/z 899 — B: MS3 product ion spectrum m/z 899 —► m/z 649 —> and C: MS4 
product ion spectrum m/z 899 —► m/z 649 —> m/z 445 —
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FNa* = m/z 445
FNa+ = m/z 649
FNa+ -MeOH = m/z 617
FNa+ - MeOH - CH20  = m/z 587
Scheme 3.4. Positive ion mode fragmentation of m/z 899 ion produced by MS2, 
m/z 649 ion produced by MS3, and m/z 445 ion produced by MS4 of 
permethylated triglycosylinositol Mana3Mana2lns.
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Figure 3.6. Positive ion mode ESI-MSn of permethylated triglycosylinositol from 
A.nidulans GIPC Mana3(Mana6)Mana2IPC. A: MS2 product ion spectrum m/z 
899 —*, B: MS3 product ion spectrum m/z 899 —> m/z 649 —
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FNa = m/z 649OCH3
Scheme 3.5. Positive ion mode fragmentation of m/z 899 ion produced by MS2, 
and m/z 649 ion produced by MS3 of permethylated triglycosylinositol 
Mana3(Mana6)Mana2lns.
Applications to more complex GIs are illustrated by the next two 
examples, both pentaglycosylinositols derived from basidiomycete GIPCs. (A  
bisporus and C. neoformans, respectively). It is worth noting that basidiomycete
66
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GIPCs typically contain Gal(36Mana2IPC core; however while mushroom GIPCs 
typically contain fucose and a-galactose residues, in their peripheral structures, 
those of C. neoformans are characterized by a-mannose chains and a highly 
distinct (B-xylose branching residue. These differences result in different 
molecular weights for the permethylated inositols, sodium adducts being 
observed at m/z 1277 and m/z 1263 respectively (molecular ion profile not 
shown). In MS2 of the precursor ion at m/z 1277 (Figure 3.7 A), glycosidic bond 
fragmentations produced ions at m/z 1089, 1059, 1027, 855 and 823 (Scheme 
3.6). The MS2 analysis of the precursor ion at m/z 1263 (Figure 3.8 A) produced 
a dominant ion at m/z 681 and other ions at m/z 1089, 1045, 1013, 809, 605, 477 
and 431 (Scheme 3.7). A dominant isobaric ion at m/z 1089 occurring in both 
spectra is consistent with the loss of a branching terminal permethylated 
deoxyhexose (188 amu) (Scheme 3.6) or a branching terminal permethylated 
pentose (174 amu) (Scheme 3.7) respectively, leaving isomeric 
tetrahexosylinositols with one open hydroxyl each.
The MS3 analysis of the A. bisporus Gl-derived tetrasaccharide-1-ene 
fragment at m/z 1027 (Figure 3.7 B, Scheme 3.6) produces an ion at m/z 911 
consistent with a cross-ring cleavage. A prominent C ion is present at m/z 841. 
The sequential losses of permethylated residues from the reducing terminal aid 
in the assignment of the position of branching. The loss of 378 amu (204+174) is 
consistent with the loss of a permethylated hexose and deoxyhexose residue. 
These results confirm a Hex-O-Hex-O-Hex (OH)-O-Hex-l-ene sequence.
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The MS3 analysis of the tetrasaccharide-1-ene fragment of the C. 
neoformans Gl-derived at m/z 1013 produces dominant C-type and cross-ring 
cleavage ions at m/z 827 and 897 respectively (Figure 3.8 B, Scheme 3.7). Also 
noticeable and distinct are ions at m/z 605 and 431. The ion at m/z 605 is 
consistent with a trisaccharide-1-ene structure. Likewise the sequential loss of 
residues from the reducing terminal gives rise to ions at various masses that can 
be used in assigning the branching position and sequence Hex-O-Hex (OH)-O- 
Hex-0-Hex-1-ene (Scheme 3.7).
Figure 3.7. Positive ion mode ESI-MSn of permethylated pentaglycosylinositol 
from A.bisporus GIPC Gala1-»6Gala 1—>6 (Fucal—>2)Gal(31—>-6Mana2IPC. A: 
MS2 product ion spectrum m/z 1277 —► and B: MS3 product ion spectrum m/z 
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FNa+ = m/z 1027 
FNa+ - 32 = m/z 995 OCH*
Scheme 3.6. Fragmentation of m/z 1277 ion produced by positive ion mode MS2 
and of m/z 1027 ion produced by positive ion mode MS3 of permethylated 
pentaglycosylinositol Galcd—>6Gala1— > 6  (Fuca1^2)Gaipi->6Mana2IPC.
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Figure 3.8. Positive ion mode ESI-MSn of permethylated pentaglycosylinositol 
from C.neoformans GIPC M anal—>3(Xyl(31—>2) M anal—>4Gal|31—>6Mana2IPC. 
A: MS2 product ion spectrum m/z 1263 —► and B: MS3 product ion spectrum m/z 
1263 —> m/z 1013 —
70
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
681
1045
477h,c o  1
—o)-- 0




OCH3 OCH;. —O OCH;Na+
OCH-OCH;
1089





FNa+ = m/z 1089
431 8 2 7
809







FNa+ = m/z 1013
Scheme 3.7. Fragmentation of m/z 1263 and m/z 1089 ion produced by positive 
ion mode MS2 and of m/z 1013 ion produced by positive ion mode MS3 of 
permethylated pentaglycosylinositol 
Manal —>3(Xyl|31 ->2)Mana1 ->4Gal(31 ^ ->6Mana2IPC.
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MS1 analysis of a hexaglycosylinositol derived from a still more complex 
GIPC from C. neoformans was consistent with a composition similar to that of the 
previous Gl, but containing one additional hexose residue, displaying a sodiated 
molecular ion at m/z 1467. Figure 3.9 A yielded Y-ions at m/z 1249, 1045, 681, 
and 477 (in a similar pattern to the fragmentation, of m/z 1263 but with peaks 
incremented by 204 amu). Glycosidic cleavages are also observed at m/z 1043, 
999, 795 and 431. The MS3 of the hexasaccharide -1-ene fragment at m/z 1217 
displayed an abundant cross-ring cleavage ion at m/z 1 1 0 1 , and a variety of 
sequence defining glycosidic cleavages, as shown in Scheme 3.8.
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Figure 3.9. Positive ion mode ESI-MSn of permethylated hexaglycosylinositol 
from C.neoformans GIPC M anal—>6Mana1—>3
(Xyl|31—>-2)Mana1—>4Galf31—>6Manc(2IPC. A: MS2 product ion spectrum m/z 
1467 —> and B: MS3 product ion spectrum m/z 1467 —► m/z 1217
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Scheme 3.8. Fragmentation of m/z 1467 ion produced by positive ion mode MS2 
and of m/z 1217 ion produced by positive ion mode MS3 of permethylated 
hexaglycosylinositol Manal —>6Mana1 —>3 
(Xyl(31->2)Mana1^4Gal|31^6Mana2IPC.
As shown in Figure 3.10, the MS5fragmentation pathway proceeding via 
the tetrasaccharide-1-ene fragment at m/z 809 i.e. m/z 1467 —> m/z 809 —»• m/z
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635 —> m/z 445 (Scheme 3.8) yields a dominant product ion at m/z 329 
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Figure 3.10. Positive ion mode ESI-MSn of permethylated hexaglycosylinositol 
from C.neoformans GIPC M anal—»6Mana1—>3
(Xyl(31-»2)Mana1—>4Gal(31 —>6Mana2IPC. A: MS4 product ion spectrum m/z 1467 
—> m/z 809 —► m/z 635-» and B: MS5 product ion spectrum m/z 1467 —» m/z 809 
—► m/z 635—► m/z 445 —
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Scheme 3.9. Fragmentation of m/z 635 ion produced by positive ion mode MS4 
and of m/z 445 ion produced by positive ion mode MS5 of permethylated 
hexaglycosylinositol Manal-»6Mana1 —>3 
(Xyipi —>2)Man1—>4Gal(31—>6Mana2IPC.
It is evident that MS of GIs provides information about sequence that 
would complement data obtained from GC-MS linkage analysis of PMAAs.
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A variety of methodologies successfully applied to GSLs have been based 
on enzymatic removal of the ceramide moiety [95-98] followed by derivatization 
of the reducing glycosyl residue of the released glycan via reductive amination 
[94], In the case of a major family of GSLs from plants and fungi, the 
glycosylinositol phosphorylceramides (GIPCs), this strategy cannot be used. 
Although chemical methods are available to release the glycosylinositol [29, 32], 
the inositol residue has no aldehyde form that can be specifically derivatized this 
way. Although previously applied only to mammalian GSLs, enzymatic 
deacylation of the ceramide moiety using the enzyme sphingolipid ceramide N- 
deacylase (SCDase) [56, 57], appeared to provide an alternative strategy that 
could be applied to all GSLs, including fungal GIPCs. Preliminary experiments in 
our laboratory confirmed that the enzyme has significant activity with GIPCs 
(Levery SB, Eichert H, Arigi EA, unpublished).
Once the amino group of the sphingoid base has been freed, GSLs can be 
coupled to any suitable amino-reactive derivatizing reagent, e.g., A/-alkyl 
benzyloxycarbonyl succinimide (Cbz-OSu) and A/-hydroxysuccinimide (NHS) 
esters. In my first series of experiments I utilized perfluoroalkyl tags (Scheme 4.1
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and 4.2) [99], Previous work has demonstrated the ability of fluorous 
functionalized silica gel or fluorous solid phase extraction to selectively bind 
fluorinated organic compounds [100-102], Fluorinated derivatives have been 
used for purification of synthetic peptides and oligosaccharides, and enrichment 
of peptide subsets of biological origin, with subsequent characterization by MS 
[103-105], Previous unpublished work in our laboratory showed that this strategy 
eliminates the problems associated with the use of bio-affinity protocols such as 
biotin-captavidin-based extractions, such as inefficient recovery of derivatives 
(Heather Eichert, Masters Thesis, 2005). It is furthermore compatible with a 
microarray printing approach utilizing fluorine-modified glass slides as the 
immobilizing surface (see Chapter V).
Ma2IPC Ma2IPSph Ma2IPSph
Scheme 4.1. Reaction of mannosyl IPC from with sphingolipid ceramide-A/- 
deacylase (SCDase) and subsequent F-tagging with F-Cbz-OSu.
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Scheme 4.2. Reaction of mannosyl IPC from A. bisporus with sphingolipid 
ceramide-A/-deacylase (SCDase) and subsequent F-tagging with F-Fmoc.
In my second approach I studied the use of a novel non-fluorinated 
bifunctional linker NHS-PEC>2 -maleimide (succinimidyl-[(A/- 
maleimidopropionamido)-diethyleneglycol] ester) attached first to the N- 
deacylated GSL via the NHS functionality, and subsequently attached to 2- 
mercaptoethylamine (2-MEA) via the maleimide functionality to generate a new 
primary amino group for reaction with NHS-functionalized glass used for printing 
of microarrays in Chapter V (Scheme 4.3). The experimental details are 
described below.
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Scheme 4.3. Reaction of galactosylsphingosine (GalSph) with NHS-PE02- 
maleimide and subsequent tagging with 2-MEA.
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Experimental Materials and Methods
A/-deacvlation of fungal GIPCs
Glycosylinositol phosphorylceramides (GIPCs) were obtained from fungal 
species (A  fumigatus, A. bisporus, and A. nidulans, P. squamosus) as described 
[39, 40, 6 8 ], De-/V-acylation was carried out with Pseudomonas sphingolipid 
ceramide de-A/-acylase (SCDase) (Takara Bio, Shiga, Japan) to generate free 
primary amine groups [56, 57], In general, 20mU of enzyme was added to the 
sample (~20-30pg) dispersed in a biphasic environment containing 10pL buffer 
(0.8% taurodeoxycholate sodium salt (TDC) in sodium acetate, pH 5.5) and 100 
pL n-decane (to partition the fatty acids away from the aqueous phase since the 
enzyme has reverse activity). Incubation was performed for 24 hours at 37°C 
with slight agitation (1 0 0 rpm on a Lab-Line Environ Shaker).
Formation of Fluorocarbon derivatives and F-SPE sample cleanup
Amino-group derivatization was carried out with prototype F-Tags™ 
(Fluorous Technologies, Pittsburgh, PA), N-[4-(1 H,1 H,2H,2H 
perfluorodecyl)benzyloxycarbonyloxyl]succinimide (Fi7-Cbz-OSu, C2 2H14F1 7NO5 , 
MW=695.33) (scheme 4.1) and A/-[2,7-Bis(1H,1H,2H,2H-perfluorooctyl)-9- 
fluorenylmethoxycarbonyloxy]succinimide (F-Fmoc, C3 5H2 1F2 6 NO5 , MW= 
1029.52)(Scheme 4.2) [103]. Derivatization trials were performed on 
commercially available and enzymatically generated lyso-GSLs (lyso-GM1 and 
galactosylsphingosine) obtained from mammals (see Appendix E for TLC 
images). The resulting derivatives were separated by FluoroFlash® SPE
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cartridges, (2 grams, 8 cc tube, Fluorous Technologies Inc., Pittsburgh, PA) using 
60-100% MeOH-H20, columns pre-conditioned according to manufacturer’s 
instructions.
Preparation of PBS-EDTA buffer pH 7.5 
20mM Na2 HP0 4  
150mM NaCI
5mM EDTA (disodium salt: dihydrate CioHi4N208Na2.2H20 )
Preparation of NHS-PEO? maleimide and 2-Mercaptoethvlamine 
A 250mM stock solution was prepared by dissolving 100mg of the 
heterobifunctional linker NHS-PE02-maleimide (succinimidyl-[(A/- 
maleimidopropionamido)-diethyleneglycol] ester) (Pierce Biotechnology, Inc., 
Rockford, IL) in 940uL of dimethylsulfoxide (DMSO) (Pierce Biotechnology, Inc., 
Rockford, IL), under conditions of minimal exposure to moisture to minimize 
hydrolysis of the NHS-ester reactive group. The vial was capped under nitrogen 
at -20°C. 6 mg of 2-mercaptoethylamine (2-MEA) (Pierce Biotechnology, Inc., 
Rockford, IL) was dissolved in 100pL of the reaction buffer (PBS-EDTA) pH 7.5. 
NHS-PEO?-maleimide-2-MEA derivatization
100pg of lyso-GM1 was dissolved in 500pL of conjugation buffer (PBS-EDTA) pH 
7.5 and 4pL of NHS-PE02-maleimide was added (Scheme 4.4). Incubation was 
performed for 1hr at room temperature with slight agitation. The sample was 
desalted on a Sep-PakR Vac C-18 SPE 1cc cartridge (Waters Corporation,
Milford MA) and eluted using 100% methanol. The PE02-NHS maleimide 
derivatized sample was dried down under N2, re-suspended in 100pL of buffer
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(PBS-EDTA), 10uL of the 2-MEA (above) was added and incubation done for 90 
minutes at 37°C to generate a derivative with a free primary amine (Scheme 
4.4). The progress of the reactions was monitored using high performance thin 
layer chromatography (HPTLC) and the mass of the expected product verified 
using ESI-MS and MALDI (dihydrobenzoic acid (DHB) as matrix).
HPTLC Analysis
HPTLC was performed on silica gel 60 plates (E. Merck, Darmstadt, 
Germany) using chloroform/methanol/water (50:40:10 v/v/v containing 0.038% 
w/v CaCh) as previously described (Chapter II).
MS Analysis
Ion trap MSn analysis was performed on a Thermo-Finnigan (San Jose, 
CA) LTQ (samples introduced via direct infusion in methanol), using parameters 
described in Chapter 111 and /or on a Kratos Shimadzu Axima-QIT and/or Axima- 
CFR MALDI-TOF-MS instruments (Manchester, UK) operated in positive ion 
mode, samples spotted on 10mg/mL DHB in 50% 0.01% trifluoroacetic acid 
(TFA) in water and 50% acetonitrile (ACN).
Results
The relatively abundant mushroom MIPC was chosen for initial trials of the 
reaction sequence (Scheme 4.1). Figure 4.1 shows the MS analysis of the 
resulting F17-Cbz-OSu-lyso-Mana2IPC derivative from P. squamosus. The MS 
analysis of the derivative gave the expected sodiated molecular adduct at m/z
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1346 (Figure 4.1 A), corresponding to one predominant sphingoid, t18:0 4- 
hydroxysphinganine. The MS2 analysis gave ions consistent with the loss of part 
or the entire fluorocarbon. The labels describing the fragments are shown with 
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Figure 4.1. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2 
analysis (B) of A/-deacylated GIPC(Ps-l) (Mana2IPC) Fi7-Cbz-OSu-tagged 
derivative from P.squamosus.
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Figure 4.2. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2 
analysis (B) of A/-deacylated GIPC (Ps-2) (Gal(36Mana2IPC) F17-Cbz-OSu- 
tagged derivative from P.squamosus.
A second trial with a diglycosyl-IPC from P. squamosus appeared to be 
successful as well. Thus, in Figure 4.2 A, a sodiated molecular adduct at m/z 
1508 corresponds to a Fi7-Cbz-OSu-lyso-Gal(36Mana2IPC derivative with an 
additional hexose (m/z 1346 + 162 amu). The MS2 analysis displayed a 
fragmentation pattern consistent with the formation of the expected product 
(Figure 4.2 B).
Figure 4.3 A shows the HPTLC analysis of the reaction of SCDase with a 
more complex GIPC, Galpa6Galpa6[Fucpa2]Gal(36Mana2IPC (BI-3) from
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Agaricus bisporus. The band in Lane 1 represents unreacted BI-3 standard. Lane 
2 represents the n-decane fraction. Lane 3 represents the reaction product from 
the enzymatic reaction. A shift of the orcinol stained band to a lower Rf value 
(Lane 3) indicates that enzymatic A/-deacylation reaction proceeded to ~ 100% 
completion. Figure 4.3 B shows the results of the subsequent F-i7 derivatization 
of the A/-deacylated BI-3. Lane 1 represents the lyso-GIPC. Lanes 2 and 3 
represent the derivatives eluted using 80 and 100% methanol in water 
respectively. The shift of the bands back to higher Rf values is consistent with the 
addition of the fluorocarbon tag. In Lane 3 the non orcinol-stained band with the 
highest Rf value represents excess un-reacted tag.
A B
M M ,
1 2  3  1 2  3
Figure 4.3 (A). HPTLC profile (silica gel 60, CHCl3-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCh) of BI-3 from A.bisporus. Lane 1, Mana2IPC, Lane 2 Decane layer, 
Lane 3 A/-deacylated GIPC (lower band). The marked band (*) does not 
correspond to a GIPC. (B). HPTLC profile (silica gel 60, CHCI3- MeOH-water, 
50:40:10 v/v/v + 0.03% CaCh) of BI-3 from A.bisporus. Lane 1 A/-deacylated BI-3, 
Lane 2 and 3 Fi7-derivatized BI-3 following F-SPE clean up. Fractions eluted in 
80%v/v MeOH-water and 100% MeOH respectively.
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The MS analysis of the BI-3 derivative is shown in Figures 4.4 and 4.5. 
The MS2 analysis of the dominant precursor ion at m/z 1978 gives rise mainly to 
glycosidic cleavage ions as shown in Scheme 4.4. The MSn analysis produced 
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Figure 4.4. Positive ion mode analysis ESI-LTQ-MS2 1978—> (A) and MS3 
1978—>1832—»(B) analysis of A/-deacylated GIPC 
Galpa6Galpa6[Fucpa2]Gal|36Mana2IPC) Fi7-Cbz-OSu-tagged derivative 
following F-SPE.
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Scheme 4.4. Fragmentation scheme of F17-Cbz-OSu-derivatized BI-3 from 
A.bisporus
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Figure 4.5. (A) MS3 (m/z 1978^1424 ^ ) ,  (B) MS4 (m/z 1978^1424 -^1278-*) 
and (C) MS (m/z 1978—>1424 —>1278 —>935—►) product ion spectra of N- 
deacylated GIPC (Galpa6Galpa6[Fucpa2]Gal|36Mana2IPC) F-i7-Cbz-OSu-tagged 
derivative.
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Derivatization with another amino group active tagging reagent, F-Fmoc 
(Scheme 4.2), was carried out, again using mushroom MIPC and a dimannosyl 
IPC from A. fumigatus for initial trials. As shown in Figure 4.6 A, the addition of 
914 amu to the molecular mass of lyso-Mana2IPC is consistent with the 
formation of the F-Fmoc-derivatized lyso-Mana2IPC. The MS profile gave a 
sodiated adduct at m/z 1680 consistent with a GIPC with a t18:0 sphingoid. The 
molecular ion adduct at m/z 1664 is unlikely to be a component with one less 
hydroxyl group (d18:0) since this sphingoid base is not observed in the fungal 
GIPC precursor. Nevertheless, in subsequent MS2 analysis, it yielded fragments 
consistent with a properly derivatized GIPC. Its origin is mysterious, but under 
investigation. Figure 4.6 B and C represent the MS2 analysis of precursors at 
m/z 1664 and 1680, respectively, with labels describing the resulting product 
ions.
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Figure 4.6. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2 
analysis of A/-deacylated mannosyl-IPC (Mana2IPC) F-Fmoc-tagged derivative 
(B and C) following F-SPE.
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Figure 4.7. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2 
analysis of A/-deacylated dimannosyl-IPC (Mana3Mana2IPC) F-Fmoc-tagged 
derivative (B and C) following F-SPE.
Figure 4.7 shows the MS analysis of the F-Fmoc-lyso-Mana3Mana2IPC 
derivative of the dimannosyl-IPC from A.fumigatus. The sodiated molecular 
adducts at m/z 1842 and 1870 are consistent with t18:0 and t20:0 sphingoid 
variants known to be present in this fraction [34], The MS2 analysis of the
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precursor ions yielded fragment ions (labeled on Figure 4.7 B and C) consistent 
with the expected products.
A mammalian ganglioside, lyso-GM1 was used in preliminary trials to 
generate an NHS-glass compatible derivative (Scheme 4.3). The HPTLC 
analysis of the reaction product of the addition of NHS-PEC>2-maleimide-2-MEA 
to the amino group of lyso-GM1 is shown in Figure 4.8. The band in Lane 1 
represents the underivatized lyso-GM1 standard. The shift of the band in lane 2 
to a higher Rf value is consistent with a NHS-PE02-maleimide-2-MEA derivatized 
lyso-GM1. The yield of the product is ~ 90%. The presence of a doublet is 
consistent with a 4-sphingenine having two chain lengths, C18 and C20, i.e. 
d18:1 and d20:1 sphingoids.
1 2
Figure 4.8. HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCI2) of lyso-GM1 lane 1 and NHS-PE02-2-MEA derivatized lyso-GM1 
lane 2 after C-18 SPE clean-up, sample eluted with 100% MeOH.
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Figure 4.9 A. MALDI-MS spectrum of lyso-GM1 B. lyso-GM1-PE02-maleimide 
derivative and C. Lyso-GM1-PE02-maleimide-2-MEA derivative.
Scheme 4.5 represents the expected product of the reaction of lyso-GM1 
with the NHS-PE02-maleimide linker. The identity of the product was confirmed 
by MALDI-TOF MS; it yielded the expected predominant sodiated molecular ions 
at m/z 1612 and m/z 1640, consistent with the d18:1 and d20:1 sphingoid
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variants. Di-sodiated [(Na)+Na]+ salt adducts were observed at m/z 1634 and 








Scheme 4.5. Structure of the expected product of the reaction of lyso-GM1 with 
NHS-PE02-maleimide.
Scheme 4.6 represents the expected product of the reaction of the 
addition of 2-MEA to the lyso-GM1 NHS-PE02-maleimide derivative. The identity 
of the product, confirmed by MALDI-TOF MS, gave the expected predominant
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sodiated molecular ions at m/z 1690 and m/z 1718, consistent with the d18:1 and 
d20:1 sphingoid variants. Corresponding [(Na)+Na]+ ions were observed at m/z 
1712 and 1740 respectively (Figure 4.9 C). Comparison can be made to the 
underivatized lyso-GM1 (Figure 4.9 A), with mono-sodiated ions at m/z 1302 and 





Scheme 4.6 Structure of the expected product of the reaction of lyso-GM1-NHS- 
PE02-maleimide derivative with 2-MEA
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Discussion
The activity of the enzyme, sphingolipid ceramide A/-deacylase (SCDase) 
[56, 57], has been well characterized with respect to mammalian GSLs and 
sphingomyelin, but was not previously tested with fungal GIPCs. The activity of 
this enzyme with GIPCs was found to be substantially similar, sufficient to 
remove the long chain 2-hydroxy fatty acid from the phytosphingosine moiety, 
generally encountered in the GIPC ceramide, while leaving the glycosylinositol 
phosphate moiety intact. The amino group of the resulting lyso-GIPC becomes 
available for reaction with a wide variety of A/-reactive tags.
For these studies the Flourous™ fluorinated hydrocarbon (F-Tag) 
methodology [103] and a novel NHS-PE02-maleimide-2-MEA linker were utilized. 
The former was chosen as part of a protocol for facilitating sample cleanup by 
Fluorous™ solid phase extraction (F-SPE), and immobilization of the derivatives 
on fluorous glass slides. The latter was chosen as part of an alternative strategy 
to facilitate sample immobilization on an /V-hydroxysuccinimide (NHS)-activated 
surface (Chapter V). The NHS-PE02-maleimide-2-MEA derivative was desalted 
and recovered by reverse phase C-18 solid phase extraction (C-18-SPE) in high 
yield.
The “one-pot” A/-deacylation and derivatization of lyso-GSLs with 
appropriate fluorocarbon tags, and their selective isolation via F-SPE, was 
successfully executed. This approach minimized the loss of products associated 
with the use of bio-affinity tags, the efficiency of which appeared to be reduced
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by the number of purification steps, inadequate binding to the stationary phase, 
and the necessity of using highly concentrated buffers for sample release. The 
use of organic solvents facilitates the subsequent direct analysis of the sample 
by MS. The compatibility of the derivatives with MS strategies was confirmed by 
the MS analysis of the samples.
Future developments could expand the utility of this technique to include 
facilitating analysis of crude GIPC extracts, although the presence of 
contaminants in the sample might interfere with the activity of the enzyme. 
Therefore, optimal conditions for maintenance of the enzyme activity will need to 
be evaluated. Since the alternative fluorocarbon, F-Fmoc possesses UV and 
fluorescence detectability, this reagent, or one with similar properties could 
potentially be used in future development of HPLC-based separation 
methodologies.
Possibilities for using the affinity between F-tagged GIPCs and 
fluorocarbon-modified surfaces, and the amine functionalized NHS-PEO2- 
maleimide-2-MEA derivatives for covalent bond immobilization on NHS-activated 
surfaces, as two potential bases for developing microarray methodologies are 
discussed in Chapter V.
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CHAPTER V
DEVELOPMENT OF GLYCOSPHINGOLIPID BASED GLYCAN MICROARRAYS
Introduction
Glycosylation plays a vital role in the development, growth, functioning 
and survival of organisms. Glycoconjugates mediate a variety of biological 
processes, including specific recognition events within cells, on cell surfaces, in 
the extracellular matrix, and in secretions, mainly via functional interactions with 
endogenous or exogenous carbohydrate-binding proteins (CBPs) [106].
The interactions of glycans with proteins and other potentially interactive 
molecules can be studied using microarrays of immobilized glycoconjugates. 
Glycoarrays are emerging as sensitive alternative tools that speed up the study 
of specific interactions between CBPs and glycans, requiring small amounts of 
material and allowing rapid screening of many protein-containing samples 
simultaneously. By observing the pattern of binding between an added protein 
and the broad range of glycans on such an array, detailed requirements for 
carbohydrate-protein interactions can be characterized, and potential candidates 
for in vivo functional interactions can be identified for further experimental study. 
Recent advances in glycan array manufacture involve covalent printing of 
derivatized glycans onto chemically activated surfaces [107-109]. The spatial 
arrangement of immobilized glycans effectively mimics their presentation on cell
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surfaces, and offers several advantages over non-covalent immobilization, such 
as minimization of non-specific binding and enhancement of ligand accessibility 
[110].
The successful use of fluorous-based non-covalently immobilized glycan 
microarrays for studying protein-ligand binding interactions was first 
demonstrated by Nicola Pohl and co-workers [111, 112]. This method has since 
been used for the screening of flourous-tagged small molecules [113]. So far, 
these systems have been used only with glycans having a free reducing end 
whereby linkers or tags can be attached via reductive amination. This may not 
fully mimic the presentation of lipid-linked glycans, and is in any case impossible 
to use with GIPCs (see discussion).
In this work the efficacy of two systems for immobilization of lyso-GSLs 
was studied (Scheme 5.1). For the first, I tested conventional, commercially 
available amine-reactive A/-hydroxysuccinimide (NHS) glass slides employing 
covalent immobilization of amine-functionalized derivatives. To facilitate this, I 
developed a novel bifunctional linker assembled from commercially available 
materials. For the second, I tested fluorous-coated slides for non-covalent 
immobilization of fluorocarbon-tagged derivatives through fluorous-fluorous 
affinity. The feasibility of these methods was tested with mammalian lyso- 
glycolipids (lyso-GM1 ganglioside and psychosine (galactosylsphingosine)) and 
lyso-GIPCs derived from fungal GIPC precursors (Chapter IV).
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Lyso-GM1-NHS-
p e o 2-
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T (i) CTX Alexa Fluor 555 orbiotin labeled PNA 
lectin-Streptavidin







Fluorescence detection of 
protein-carbohydrate 
Interaction
Scheme 5.1. Immobilization of fluoroucarbon- and NHS-PE02-maleimide-tagged 
lyso-GM1 and interaction with carbohydrate binding proteins of interest.
Printing buffer: Sodium phosphate pH 8.5
150mM of sodium phosphate buffer was prepared from a 300 mM 6X printing 
buffer stock solution.
Washing buffer I: 3X PBS-Tween (PBS-~Q pH 7.5 preparation
2.5mL Tween 20
0.5 L 10X PBS
5L milli-Q water
Blocking solution
50mM ethanolamine in 50mM sodium borate pH 9.2.
Washing buffer II: PBS without tween 
0.5 L 10X PBS 
5L milli-Q water
Experimental Materials and Methods
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Incubation buffer: PL1-P buffer pH 7.2 
29.2 g NaCI 
0.2 g KCI 
0.2 g KH2P 04 
1.15 g Na2 HP0 4 .2 H2 0  
10 g BSA 
10mL Triton-X-100
Dissolved in 1L milli-Q water (pH adjusted to 7.2 using 2 drops of 1M NaOH). 
Cholera toxin B (recombinant) Alexa Fluor 555 conjugate preparation 
1 .Omg/mL Cholera toxin B (CTX-B) (recombinant) Alexa Fluor 555 conjugate 
(Molecular Probes Inc. Eugene, OR) was prepared by dissolving 100pg powder 
in 0.1 mL of PBS pH 7.4 and the solution stored at 2-5°C.
PNA Lectin preparation
1 mg/mL of biotinylated PNA lectin from Arachis hypogaea (peanut) (Sigma Saint 
Louis, MO) dissolved in PBS pH 7.4 was diluted in the same buffer to make 2.5, 
5 and 10 pg/mL solutions.
Streptavidin DvLiqht ™ 547 preparation
Streptavidin DyLight™ 547 (Pierce Biotechnology, Inc., Rockford, IL), (pink 
colored liquid at a concentration of 1 mg/mL in 0.1 M sodium phosphate, 0.15M 
sodium chloride, pH 7.2, containing 1% BSA and 0.02% sodium azide). 
Preparation of samples for printing
The fluorocarbon tagged samples were dissolved in 50% methanol in 
water prior to being spotted and diluted in the same solvent to various
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concentrations viz. ~100pM, 50|jM , 25|jM , 12.5|jM, 6.25|jM  and 3.125 pM. The 
NHS-PE02-maleimide-2-MEA derivatives were dissolved in 150mM print buffer 
and likewise diluted to the same concentrations above.
Printing of NHS-activated and fluorinated glass slides
Fluorocarbon tagged and NHS-PE02-maleimide-2-MEA derivatives were 
spotted on the fluorous glass slides (Fluorous Technologies, Pittsburgh, PA) and 
NHS-activated glass slides (NexterionR slide MPX 16) (Schott Nexterion, Mainz, 
Germany) using a Microgrid II arrayer (Biorobotic, Cambridge, United Kingdom). 
A total of six compounds were spotted onto the slides at 5 different 
concentrations in replicates.
Blocking of slides
The NHS-activated slide was washed in 3X PBS-T and the buffer replaced 
three times every 5 minutes in a 50ml_ Falcon tube, followed by one rinse with 
milli-Q water. The slide was immersed in blocking solution and left to stand for 
1 hr after which it was placed in a 50% humidity chamber for 1 hr. The wash steps 
were repeated once more and the slide dried by centrifugation for 5 min. The 
blocking step was omitted for the fluorous glass slide.
Binding assay
A silicone based superstructure supplied with the NHS-slides in a 16 well 
format was used to partition the NHS-activated slide, and the appropriate 
conjugate was added to the wells. In order to determine a suitable working range, 
10, 5 and 2.5 pg/mL of biotin labeled PNA lectin was added to wells 2, 4 and 6 
respectively, and incubation performed in the dark for 1 hr. 5ug/mL of PNA lectin
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was selected as a suitable working concentration for subsequent binding 
experiments. The wells were then rinsed 3 times with 100pl_ of PBS-T washing 
buffer at 5 minute intervals. Incubation was done using 50pl_ of Streptavidin 
DyLight™547 diluted 5000 times in PLI-P conjugation buffer was added to the 
same wells. 50pL of Cholera toxin-Alexa Fluor 555 diluted 5000 times in the 
same conjugation buffer added to wells 10,12 and 14 was used to perform single 
step incubation. The fluorous glass slide was marked with a paraffin pen and the 
conjugates added likewise using a fixed concentration of lectin (5pg/mL). 
Incubation was performed in the dark for 1 hr. At the end of the incubation the 
slides were washed 3 times with PBS-T and once with PBS without tween. The 
slides were immersed in PBS on a slide tray before being dried down by 
centrifugation.
Scanning of slides
The fluorescent images of glass slides (microarrays) were acquired using 
the Array Worx Microarray Scanner (Applied Precision LLC, Issaquah WA).
Results and Discussion
The slides were probed with fluorophore-conjugated CTX and a sandwich 
assay using fluororophore-conjugated streptavidin and biotinylated-PNA lectin. 
The fluorescence images of the scanned glass slides are presented in Figures 
5.1 and 5.2. In both slide formats, fluorescence was observed on areas where 
lyso-GM1 was spotted. Lyso-GM1 appeared to remain active as a binding
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receptor for CTX. The PNA lectin, known to have a binding specificity for Gaipi- 
3GalNAc-R structures, also bound preferentially to lyso-GM1, which has the 
structure Gal(31 -3GalNAc[31 -4[Neu5Aca(2,3)]Gal(31 -4GIcf31 -1 'sphingosine 
(Figures 5.1 and 5.2). These results illustrate the specificity of binding to lyso- 
GM1 by CTX and PNA lectin. Overall, the spots were reproducible in both slide 
formats. There was some low background fluorescence in the unblocked fluorous 
slides; however, this did not interfere with the analyte detection. The covalent 
binding through amide bond formation on the NHS glass slide seemed to provide 
a stronger binding efficiency than the non-covalent affinity binding on the fluorous 
glass slide. The differences were evident in the ability to detect lower 
concentrations of lyso-GM1 on the NHS slides compared to the fluorous slides. 
Detection limits were tested in the concentration range ~100-3.125uM for the 
NHS-activated slide (Figure 5.1) and ~100-25pM for the fluorous-activated slides 
(Figure 5.2).
The effect of using the linker on the detection of affinity interactions was 
also assessed. Since commercially available lyso-GSLs already have a free 
primary amine group, I performed preliminary experiments with both derivatized 
and non-derivatized lyso-GM1 on the NHS-activated slide at the same sample 
concentrations. This enabled comparisons of the efficiency of binding of ligand to 
the analyte, and of the analyte to the the surface, with and without the intervening 
linker (Figure 5.1) to be made. The ligand binding appeared to be enhanced by 
the presence of linker, consistent with increased accessibility of the glycans to 
the CBPs. At this point it is unclear whether the difference in apparent binding is
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due solely to enhancement of the glycan-CBP interaction to the glass surface. 
The amount (density) of GSL bound could be influenced by the presence of the 
linker. More importantly, the feasibility of the immobilization of GSLs for 
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Figure 5.1. Fluorescence images of GSLs arrayed on an NHS-slide. Columns of 
5 spots each ~ 100, 50, 25, 12.5 and 6.25 uM incubated with cholera toxin B 
(recombinant) Alexa Fluor 555 conjugate (A) and biotin labeled PNA lectin- 
Streptavidin DyLight™ 547 conjugate (B).
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Figure 5.2. Fluorescence images of GSLs arrayed on a fluorous slide. Columns 
of 3 spots each ~ 100, 50 and 25 pM incubated with cholera toxin B 
(recombinant) Alexa Fluor 555 conjugate (A) and 5pg/mL of biotin labeled PNA 
lectin-Streptavidin DyLight™ 547 conjugate (B).
Conclusions and Future Studies
The ability of the fluorocarbon tail (C8Fi 7) and the prototype PE02-NHS- 
maleimide-2-MEA linker to provide simple and efficient means for immobilization 
of GSLs has been demonstrated. These protocols could potentially be used to 
fabricate GSL-based glycan microarrays. The conditions used for generating the 
derivatives appear to be substantially mild as to maintain CBP-binding structure 
of the lyso-GM1, and allowed the measurement of potentially functional protein- 
carbohydrate interactions to be made. Since the presence of a linker enhanced 
the apparent binding efficiency of the ligand, experimentation with different 
linkers could be performed.
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With appropriate controls and a variety of CBPs, this protocol could be 
optimized and used for screening GSLs (in the context of our project, fungal 
GIPCs), where quantitative profiles could be obtained and directly related to 
efficiency of glycan-protein interactions. In practice, for example, comparisons of 
differential anti-GSL antibody expression patterns could be used as indicators for 
various pathological states. This could lead to development of diagnostics for 
conditions eliciting expression of high titers of circulating antibodies specific for 
epitopes carried on GSLs. This could be applied, for example, for diagnostic 
identification of fungal pathogens in cases of disseminated mycosis. The basis 
for this has been suggested by studies showing reactivity of human antisera with 
fungal GSLs.
Overlay immunostaining has been used to assess the reactivity of GIPCs 
from the opportunistic mycopathogen A. fumigatus and non-pathogenic fungus 
A. nidulans, separated on thin-layer chromatograms, against sera from a patient 
with aspergillosis [34], Specific GIPC components from A. fumigatus reacted with 
serum, while none from the A. nidulans appeared to be reactive. With the 
growing appreciation of glycan microarrays for performing high-throughput 
functional studies, we are optimistic that GSL-based glycan microarrays could be 
developed using fungal GIPCs or mammalian GSLs which are immobilized and 
probed with antibodies from patients’ sera. This approach would minimize the 
sample size and allow parallel screening of multiple samples.
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Figure A.1. Sphingolipid biosynthesis in animals and fungi.
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Figure B.1. Partial total ion chromatogram of FAME 
and sphingoid component analysis.
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Figure B.3. Mass spectrum of h23:0 FAME derivative.
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Fig B.5. Mass spectrum of A/-acetyl-1,3,4-tri-O-trimethylsilyl 
t18:0 4-hydroxysphinganine.
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[M]+ [M -15f 
Due to loss of
c h 3
[M-59]+




h22:0 442 427 383
h23:0 456 441 397
h24:0 470 455 411
dh16:0 446 431 387
dh24:0 558 543 499
Table B.1. Interpretation of ions from GC-MS analysis of fatty acid methyl 
esters.
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Figure B.6. Chromatogram of dihydroxy fatty acid (dh24:0) FAME.
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Figure B.7. Mass spectrum of dh24:0 FAME derivative.
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Figure B.8. Partial ion chromatogram of erythro form of 2,3-dihydroxy palmitic 
acid (d16:0).
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Figure B.9. Mass spectrum of erythro form of dh16:0 FAME derivative.
30.08
' I ' 1'   ' I 1 '
1 3 0 0  1 4 0 0
2 5 : 4 3  2 7 : 2 3
1 5 0 0  1 6 0 0
2 9 : 0 3  3 0 : 4 3
1 7 0 0  1 8 0 0
3 2 :2 3  3 4 :0 3
Figure B.10. Partial ion chromatogram ofthreoform of 2,3-dihydroxy palmitic 
acid (d16:0).
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Figure B.11. Mass spectrum ofthreoform of dh16:0 FAME derivative.
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APPENDIX C 
GLYCOSYL LINKAGE ANALYSIS OF PARTIALLY METHYLATED ALDITOL 
ACETATES (PMAAs) BY GC-MS.
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PERMETHYLATION ■ 
SAMPLE in DMSO
ACID REDUCTION- - ACETYL ATION
NaOH CLLI
LLE extraction using CH2C12/H20  
Dry under N2
0.5 N 10mg/mLNaBD4
H2S04 in 90% HAc inHzO
80°C, 7-6 hrs glacial acetic acid
Neutralize using NaOH
' i , i
Dry under N2, 35°C Dry in vacuo 









Scheme C.1. Summary of the steps leading to formation of PMAAs.
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Figure C.1. (A) Chromatogram of FAME derivatized Ps-1 and (B) Mass 
spectrum of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-mannitol.
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Terminal mannose (t-Manp) derivative
l,5-di-0-acetyl-l-deuterio-2,3,4,6-tetra-0-methyl-mannitol
Scheme C.2. Characteristic fragmentation of 1,5-di-0-acetyl-1-deuterio-2,3,4,( 
tetra-O-methyl-mannitol.
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Figure C.2. (A) Chromatogram of FAME derivatized Ps-2 and (B) Mass 
spectrum of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-mannitol.
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Figure C.3. Mass spectra (A) of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0- 
methyl-galactitol and (B) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0-methyl- 
mannitol.
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Terminal galactose (t-Gal/;) derivative
l,5-di-0-acetyl-l-deuterio-2,3,4,6-tetra-0-methyl-galactitol

















C H 2O A c
6-linked mannose (6-Man/;) derivative 
1,5,6-tri-O-acetyl-1 -deuterio-2,3,4-tri-0-methyl-mannitol
Scheme C.4. Characteristic fragmentation of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4- 
tetra-O-methyl-mannitol.
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Figure C.4. (A) Chromatogram of FAME derivatized Ps-5 and (B) Mass 
spectrum of 1,3,5-tri-0-acetyl-1-deuterio-6-deoxy-2,4-di-0-methyl-galactitol.
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Scheme C.5. Characteristic fragmentation of 1,3,5-tri-0-acetyl-1-deuterio-6- 
deoxy-2,4-di-0-methyl-galactitol.
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Figure C.5. Mass spectra (A) of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0- 
methyl-mannitol and (B) of I^.S-tri-O-acetyl-l-deuterio-S^^-tri-O-methyl- 
galactitol.
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2-linked galactose (2-Gal/?) derivative 
1,2,5 -tri-O-acetyl -1 -deuteri o-3,4,6-tri-O-methyl -gal acti tol
Scheme C.6. Characteristic fragmentation of 1,2,5-tri-0-acetyl-1-deuterio-3,4,6- 
tri-O-methyl-galactitol.
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Figure C.7. Mass spectra (A) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0- 
methyl-mannitol and (B) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0-methyl- 
galactitol.
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6-linked galactose (6-Gal/?) derivative
l,5 ,6 -tr i-0 -a c e ty l- l-d e u te r io -2 ,3 ,4 -tr i-0 -m e th y l-g a la c tito l
Scheme C.7. Characteristic fragmentation of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4- 
tetra-O-methyl-galactitol.
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APPENDIX D 
Coprinus cinereus SUPPLEMENTARY DATA.
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Figure D.1. HPTLC analysis of GIPC fruiting body fractions isolated from 
C.cinereus corresponding to lanes 1-3 (fractions 29-31) from HPLC.
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Figure D.2. A, B and C, downfield expansions (4.00-5.60 ppm) of 1-D1H-NMR 
spectra (500MHz; DMSO-cfe 2%D20; 35°C) of GIPC fruiting body fractions 
isolated from C.cinereus; spectra acquired on fractions corresponding to lanes 1- 
3 (fractions 29-31) from HPLC C.cinereus (40 X 2ml fractions collected at 
0.5ml/min); Lane C, crude GIPC fraction.
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Figure D.3. MS3 analysis of fraction 30: Panel A, m/z 1072—>662—► and Panel B, 
m/z 1086—>676—>.
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1 2 C 3 4
Figure D.4. HPTLC (orcinol stain) of GIPCs from C.cinereus. Mobile phase 
chloroform-methanol-water (50:47:14 v/v/v) containing 0.038% w/v CaCI2. Lane 
C, GIPC standard containing Mana2IPC (MIPC), Lane 1-4 crude acidic fractions 
from C.cinereus mycelia.
S 1 2 3 S
Figure D.5. HPTLC (orcinol stain) of neutral lipids from C.cinereus mycelia. 
Mobile phase chloroform-methanol-water (60:30:5 v/v/v). Lane S, standard 
containing GlcCer.
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APPENDIX E 
PERMETHYLATED GLYCOSYLINOSITOLS SUPPLEMENTARY DATA.
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Figure E.1. Positive ion mode ESI-MSn of permethylated pentaglycosylinositol 














Figure E.2. Positive ion mode ESI-MSn of permethylated hexaglycosylinositol 
from C.neoformans GIPC M anal—»6Mana1—>3 
(Xyipi —>2)Mana1 ->4Gal|31 —>6Mana2IPC.
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APPENDIX F
CHAPTER IV SUPPLEMENTARY DATA.
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Figure F.1. HPTLC profile (silica gel 60, CHCI3-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCb) of MIPC from A.bisporus. Lanes S, Mana2IPC, Lanes 1 and 3 N- 
deacylated MIPC (lower band). Lanes 2 and 4 decane layer.
S 1 2 S 3 4
Figure F.2. HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCh) of dimannosyllPC (Af-2) from A.fumigatus. Lanes S, 
Mana3Mana2IPC, Lanes 1 and 3 A/-deacylated Af-2 (lower band). Lanes 2 and 4 
decane layer.
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1 2 3
Figure F.3. HPTLC profile (silica gel 60, CHCl3-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCfe) of lyso-GM1 lanel and F17-Cbz-OSu derivatized lyso-GM1 lanes 2 
and 3.
< . . , ' , - 0 I •; . i  t  i.~ i    i t*
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Figure F.4. HPTLC profile (silica gel 60, CHCI3-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCI2) of psychosine lanel and F17-Cbz-OSu derivatized psychosine 
lanes 2 -5.
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1 2
Figure F.5. HPTLC profile (silica gel 60, CHCI3-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCh) of F-Fmoc derivatized lyso-GM1(40ug) lane 1 and lyso-GM1 
standard lane 2.
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1 2 3 4 5 6 7 8 S
Figure F.6. HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v + 
0.03% CaCI2) of F-Fmoc derivatized lyso-GMl following F-SPE clean up. 
Fractions eluted in 40% v/v MeOH-H20  (Lanesland 2), 60% MeOH- H20  (lanes 
3and 4), 80%v/v MeOH- H20  (lanes 5and 6), and 100% MeOH (lanes 7and 8). 
Lane S is lyso-GM1 standard.
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